>sp|P22325|A1AS_CAVPO Alpha-1-antiproteinase S precursor (Alpha-1-antitrypsin) (Alpha-1- 
MPSAIPRGLLLLAGLCCLVFGIMAEDAQVAQGPSQQIPRSLAHFAHSMYRVLTQQSNTSN
IFFSPVSIATALAMVSVGAKGDTHTQILRGLEFNLTEIAEADIHNGFQNLLHTLNRPHSE
HQLTTGNGLFLDQKLKLKEKFSEDVKTLYHAEAFPTNFSNPKEAEKQINAYVEKGTQGKI
VDLVKDLSADTVLALVNYIFFRGKWEKPFDVKHTTQEDFHVDTSTTVKVPMMKREGKYKA
FHCSTIQSWVLLLDYEGNVTALFLLPEEGKMQHLEETLTPELIFKFARKTERMFANVHLP
KLSISGTYDLKEVLGHLGITNVFSDAADLSGVTEDIPLKISKGLHKALLTIDEKGTEAAG
ATMMEFMPMSLPEDLSFNKPFLFLIIDHSTDTPLFVGKVMDPTKK
>sp|P08697|A2AP_HUMAN Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) 
MALLWGLLVLSWSCLQGPCSVFSPVSAMEPLGRQLTSGPNQEQVSPLTLLKLGNQEPGGQ
TALKSPPGVCSRDPTPEQTHRLARAMMAFTADLFSLVAQTSTCPNLILSPLSVALALSHL
ALGAQNHTLQRLQQVLHAGSGPCLPHLLSRLCQDLGPGAFRLAARMYLQKGFPIKEDFLE
QSEQLFGAKPVSLTGKQEDDLANINQWVKEATEGKIQEFLSGLPEDTVLLLLNAIHFQGF
WRNKFDPSLTQRDSFHLDEQFTVPVEMMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVV
LVPTHFEWNVSQVLANLSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELF
QAPDLRGISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIF
EDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPM
EEDYPQFGSPK
>sp|P17944|A85A_MYCTU Antigen 85-A precursor (85A) (Antigen 85 complex A) (Ag85A) (Mycolyl 
MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGAFSRPGLPVEYLQVPSPS
MGRDIKVQFQSGGANSPALYLLDGLRAQDDFSGWDINTPAFEWYDQSGLSVVMPVGGQSS
FYSDWYQPACGKAGCQTYKWETFLTSELPGWLQANRHVKPTGSAVVGLSMAASSALTLAI
YHPQQFVYAGAMSGLLDPSQAMGPTLIGLAMGDAGGYKASDMWGPKEDPAWQRNDPLLNV
GKLIANNTRVWVYCGNGKPSDLGGNNLPAKFLEGFVRTSNIKFQDAYNAGGGHNGVFDFP
DSGTHSWEYWGAQLNAMKPDLQRALGATPNTGPAPQGA
>sp|P09230|AEP_YARLI Alkaline extracellular protease precursor (EC 3.4.21.-) (AEP). 
MKLATAFTILTAVLAAPLAAPAPAPDAAPAAVPEGPAAAAYSSILSVVAKQSKKFKHHKR
DLDEKDQFIVVFDSSATVDQIASEIQKLDSLVDEDSSNGITSALDLPVYTDGSGFLGFVG
KFNSTIVDKLKESSVLTVEPDTIVSLPEIPASSNAKRAIQTTPVTQWGLSRISHKKAQTG
NYAYVRETVGKHPTVSYVVDSGIRTTHSEFGGRAVWGANFADTQNADLLGHGTHVAGTVG
GKTYGVDANTKLVAVKVFAGRSAALSVINQGFTWALNDYISKRDTLPRGVLNFSGGGPKS
ASQDALWSRATQEGLLVAIAAGNDAVDACNDSPGNIGGSTSGIITVGSIDSSDKISVWSG
GQGSNYGTCVDVFAPGSDIISASYQSDSGTLVYSGTSMACPHVAGLASYYLSINDEVLTP
AQVEALITESNTGVLPTTNLKGSPNAVAYNGVGI
>sp|P07883|AGAR_STRCO Extracellular agarase precursor (EC 3.2.1.81). 
MVNRRDLIKWSAVALGAGAGLAGPAPAAHAADLEWEQYPVPAAPGGNRSWQLLPSHSDDF
NYTGKPQTFRGRWLDQHKDGWSGPANSLYSARHSWVADGNLIVEGRRAPDGRVYCGYVTS
RTPVEYPLYTEVLMRVSGLKLSSNFWLLSRDDVNEIDVIECYGNESLHGKHMNTAYHIFQ
RNPFTELARSQKGYFADGSYGYNGETGQVFGDGAGQPLLRNGFHRYGVHWISATEFDFYF
NGRLVRRLNRSNDLRDPRSRFFDQPMHLILNTESHQWRVDRGIEPTDAELADPSINNIYY
RWVRTYQAV
>sp|P31696|AGRI_CHICK Agrin precursor. 
MWPAHRNELMLNSSLMRITLRNLEEVEHCVEEHRKLLADKPNSYFTQTPPTPRDACRGML
CGFGAVCERSPTDPSQASCVCKKTACPVVVAPVCGSDYSTYSNECELEKAQCNQQRRIKV
ISKGPCGSKDPCAEVTCSFGSTCVRSADGQTAGCVCPASCSGVAESIVCGSDGKDYRSEC
DLNKHACDKQENVFKKFDGACDPCKGILNDMNRVCRVNPRTRRVELLSRPENCPSKREPV
CGDDGVTYASECVMGRTGAIRGLEIQKVRSGQCQHQDKCKDECKFNAVCLKRWHARCSCD
RITCDGTYRPVCARDSRTYSNDCERQKAECHQKAAIPVKHSGPCDLGTPSPCLSVECTFG
ATCVVKNREPVCECQQVCQGRYDPVCGSDNRTYGNPCELNAMACVLKREIRVKHKGPCDR
CGKCQFGAICEAETGRCVCPTECVPSSQPVCGTDGNTYGSECELHVRACTQQKNILVAAQ
GDCKSCGTTVCSFGSTCVGGQCVCPRCEQQPLAQVCGTDGLTYDNRCELRAASCQQQKSI
EVAKMGPCEDECGSGGSGSGDGSECEQDRCRHYGGWWDEDAEDDRCVCDFTCLAVPRSPV
CGSDDVTYANECELKKTRCEKRQNLYVTSQGACRALTTTPPPLPVVHCSQTIYGCCPDNM
TLALGVGAAGCPSTCQCNPYGSYGGTCDPATGQCSCKPGVGGLKCDRCEPGFWNFRGIVT
DSKSGCTPCNCDPVGSVRDDCEQMTGLCSCKTGITGMKCNQCPNGSKMGMAGCEKDPSAP
KSCEEMSCEFGATCVEVNGFAHCECPSPLCSEANMTKVCGSDGVTYGDQCQLKTIACRQG
QLITVKHVGQCHESITHTSHTMPPTPLPTLPLDKLIVPPPLQLTTQAPEPTELATTSLLM
EASPTTRSHPTTRRVTTTRPVTTPWMTHGVLKTTVRPLSTSPVVLATTQPPYAESGSAEG
SGDQEMSISGDQESSGAGSAGEEEVEESQVTPTPAIERATCYNTPLGCCSDGKTAAADAE
GSNCPATKVFQGVLILEEVEGQELFYTPEMADPKSELFGETARSIESALDELFRNSDVKN
DFKSIRVRDLGQSSAVRVIVESHFDPATSYTAADVQAASLKQIRASKKRTILVKKPQQEH
VKFMDFDWIPRIFTTTITTTTATTMAPATTRRHTTASAATTAHILRQDTVGHPSAKLAAP
ASTRRPTSTLPTTARRKPTRQPPSTTKKPSRPCDSHPCLHGGTCEDDGREFTCRCPAGKG
GAVCEKPIRYFIPSFGGKSYLAFKMMKAYHTVRIAMEFRATELSGLLLYNGQNRGKDFIS
LALVGGFVELRFNTGSGTGVITSKVRVEPGKWHQLVVNRNRRSGMLAVDGEHVSGESPTG
TDGLNLDTDLFVGGAPEDQMAVVAERTAATVGLKGSIRLLDVNNQMYDLREKGSDVLYGS
GVGECGNDPCHPNPCHHGASCHVKEAEMFHCECLHSYTGPTCADERNPCDPTPCHISATC
LVLPEGGAMCACPMGREGEFCERVTEQDHTMPFLPEFNGFSYLELNGLQTLFLTCRQMSM
EVVFLAKSPSGMIFYNGQKTDGKGDFVSLALHDGYLEYRYDLGKGAAVLRSKEPVPLNTW
ISVLLERSGRKGVMRINNGERVMGESPKSRKVPHAFLNLKEPFYVGGAPDFSKLARAAAI
STSFYGAVQRISIKGVPLLKEQHIRSAVEISTFRAHPCTQKPNPCQNGGTCSPRLESYEC
ACQRGFSGAHCEKVIIEKAAGDAEAIAFDGRTYMEYHNAVTKSPDALDYPAEPSEKALQS
NHFELSIKTEATQGLILWSGKGLERSDYIALAIVDGFVQMMYDLGSKPVVLRSTVPINTN
HWTHIKAYRVQREGSLQVGNEAPITGSSPLGATQLDTDGALWLGGMERLSVAHKLPKAYS
TGFIGCIRDVIVDRQELHLVEDALNNPTILHCSAK
>sp|Q03288|AGSW_MOUSE Agouti switch protein precursor (Agouti signaling protein). 
MDVTRLLLATLVSFLCFFTVHSHLALEETLGDDRSLRSNSSMNSLDFSSVSIVALNKKSK
KISRKEAEKRKRSSKKKASMKKVARPPPPSPCVATRDSCKPPAPACCDPCASCQCRFFGS
ACTCRVLNPNC
>sp|P21848|ALB1_SALSA Serum albumin 1 precursor. 
MQWLSVCSLLVLLSVLSRSQAQNQICTIFTEAKEDGFKSLILVGLAQNLPDSTLGDLVPL
IAEALAMGVKCCSDTPPEDCERDVADLFQSAVCSSETLVEKNDLKMCCEKTAAERTHCFV
DHKAKIPRDLSLKAELPAADQCEDFKKDHKAFVGRFIFKFSKSNPMLPPHVVLAIAKGYG
EVLTTCCGEAEAQTCFDTKKATFQHAVMKRVAELRSLCIVHKKYGDRVVKAKKLVQYSQK
MPQASFQEMGGMVDKIVATVAPCCSGDMVTCMKERKTLVDEVCADESVLSRAAGLSACCK
EDAVHRGSCVEAMKPDPKPDGLSEHYDIHADIAAVCQTFTKTPDVAMGKLVYEISVRHPE
SSQQVILRFAKEAEQALLQCCDMEDHAECVKTALAGSDIDKKITDETDYYKKMCAAEAAV
SDDSFEKSMMVYYTRIMPQASFDQLHMVSETVHDVLHACCKDEQGHFVLPCAEEKLTDAI
DATCDDYDPSSINPHIAHCCNQSYSMRRHCILAIQPDTEFTPPELDASSFHMGPELCTKD
SKDLLLSGKKLLYGVVRHKTTITEDHLKTISTKYHTMKEKCCAAEDQAACFTEEAPKLVS
ESAELVKV
>sp|P14872|ALB2_XENLA 74 kDa serum albumin precursor. 
MKWITLICLLISSSFIESRILFKRDTDADHHKHIADVYTALTERTFKGLTLAIVSQNLQK
CSLEELSKLVNEINDFAKSCINDKTPECEKPVGTLFFDKLCADPAVGVNYEWSKECCAKQ
DPERAQCFKAHRDHEHTSIKPEPEETCKLLKEHPDDLLSAFIHEEARNHPDLYPPAVLAL
TKQYHKLAEHCCEEEDKEKCFSEKMKQLMKQSHSIEDKQHHFCWILDNFPEKVLKALNLA
RVSHRYPKAEFKLAHNFTEEVTHFIKDCCHDDMFECMTERLELTEHTCQHKDELSSKLEK
CCNIPLLERTYCIVTLENDDVPAELSQPITEFTEDPHVCEKYAENNEVFLGRYLHAVSRK
HQELSEQFLLQSAKEYESLLNKCCKTDNPPECYKDGADRFMNEAKERFAYLKQNCDILHE
HGEYLFENELLIRYTKKMPQVSDETLIGIAHQMADIGEHCCAVPENQRMPCAEGDLTILI
GKMCERQKKTFINNHVAHCCTDSYSGMRSCFTALGPDEDYVPPPVTDDTFHFDDKICTAN
DKEKQHIKQKFLVKLIKVSPKLEKNHIDECSAEFLKMVQKCCTADEHQPCFDTEKPVLIE
HCQKLHP
>sp|P36953|AFAM_RAT Afamin precursor (Alpha-albumin) (Alpha-Alb). 
MRHLKLTGFIFFLLSLTESLALPTKPQDVDHFNATQKFINENVAYLTIIASAQYVQEASF
EEVEMLVKVMLDYKDRCLADSTLPECSKIANDAIQDMLCDMKGLPQKHNFSHCCRQAGFQ
RRLCFFYNKKANVGFLPPFPTLDPEEKCQAYKNNSESFLNLYMYEVARRNPFAFAPVLLN
VAARFEEAATTCCEQQQKATYFQDKAAPITQYLKALSSYQRNVCGALLKFGPKTLNSINI
AVFSKKFPKIGFEDLTSLLEDVSSMYDGCCEGDVVQCIRSQSQVMHHICSKQDSISSKIK
ACCEKKLPERADCIINANKDDRPEDLSLRTPKFTDSENVCQERDSEQDKFFAEFLYDYSR
RHTELSTPELLRITKVYKDLLEDCCNRKNPLSCYRHAEDKFNETTERSLAMVQQECKQFQ
ELGKDALQRHFLVKFTKAAPQLPMEELVSLSKEMVAALATCCTLSDEFACVDNLADLVLG
ELCGMNKNRTINPTVDHCCRADFAFRRPCFEHLKADTTYALPSVSALVSALRADWCQPLK
EDLQNKRHRFLVNLVKWMPEITDEERLCLFTKFTAAGEECGNIQKPEACFSPESSKTGDV
SQDAEKQR
>sp|P23616|ALDC_BACBR Alpha-acetolactate decarboxylase precursor (EC 4.1.1.5) (ALDC). 
MKKNIITSITSLALVAGLSLTAFAATTATVPAPPAKQESKPAVAANPAPKNVLFQYSTIN
ALMLGQFEGDLTLKDLKLRGDMGLGTINDLDGEMIQMGTKFYQIDSTGKLSELPESVKTP
FAVTTHFEPKEKTTLTNVQDYNQLTKMLEEKFENKNVFYAVKLTGTFKMVKARTVPKQTR
PYPQLTEVTKKQSEFEFKNVKGTLIGFYTPNYAAALNVPGFHLHFITEDKTSGGHVLNLQ
FDNANLEISPIHEFDVQLPHTDDFAHSDLTQVTTSQVHQAESERK
>sp|P39046|MUR2_ENTHR Muramidase-2 precursor (EC 3.2.1.17) (1,4-beta-N- 
MENIARKERRRLNETKRFRKVKRSAALVGTAMVGCSVAAPLIQPVQVDADQTPTQFGARI
NTAAFIAEIATYAQPIAQANDLYASVMIAQAVVESGWGSSALSQAPYYNLFGIKGSYQGQ
TVYMDTLEYLNNKWVSKKEPFRQYPSFAESFNDNAYVLRNTSFGNGYYYAGTWKSNTKSY
TDATACLTGRYATDPGYAGKLNNIITTYGLTKYDTPASGNAGGGVTIGNGGNTGNTSNSG
STSGNSGGSATTTGTTYTVKSGDSVWGISHSFGITMAQLIEWNNIKNNFIYPGQKLTIKG
GQSAGSSTTNTGNNASSGNTSGNTNTSGSTGQATGAKYTVKSGDSVWKIANDHGISMNQL
IEWNNIKNNFVYPGQQLVVSKGSSSASGSTSNTSTGNTSSNTANTGSTTSGSTYTVKAGE
SVWSVSNKFGISMNQLIQWNNIKNNFIYPGQKLIVKGGSSSSNASTSTANNKNTASSNTS
STATGQATYTVKAGESVWGVANKNGISMNQLIEWNNIKNNFIYPGQKLIVKGGSSKASAT
ATIKPTASTPASTTPTASSTGDTKYTVKAGESVWGVANKHHITMDQLIEWNNIKNNFIYP
GQEVIVKKGTAQSTPAKSDEKTYTVKAGESVWGVADSHGITMNQLIEWNNIKNNFIYPGQ
QLIVKK
>sp|P45559|AMEL_MOUSE Amelogenin precursor [Contains: Leucine-rich amelogenin peptide 
MGTWILFACLLGAAFAMPLPPHPGSPGYINLSYEVLTPLKWYQSMIRQPYPSYGYEPMGG
WLHHQIIPVLSQQHPPSHTLQPHHHLPVVPAQQPVAPQQPMMPVPGHHSMTPTQHHQPNI
PPSAQQPFQQPFQPQAIPPQSHQPMQPQSPLHPMQPLAPQPPLPPLFSMQPLSPILPELP
LEAWPATDKTKREEVD
>sp|P15514|AMPR_HUMAN Amphiregulin precursor (AR) (Colorectum cell-derived growth factor) 
MRAPLLPPAPVVLSLLILGSGHYAAGLDLNDTYSGKREPFSGDHSADGFEVTSRSEMSSG
SEISPVSEMPSSSEPSSGADYDYSEEYDNEPQIPGYIVDDSVRVEQVVKPPQNKTESENT
SDKPKRKKKGGKNGKNRRNRKKKNPCNAEFQNFCIHGECKYIEHLEAVTCKCQQEYFGER
CGEKSMKTHSMIDSSLSKIALAAIAAFMSAVILTAVAVITVQLRRQYVRKYEGEAEERKK
LRQENGNVHAIA
>sp|P17692|AMYR_BACS8 Raw-starch-digesting amylase precursor (EC 3.2.1.1) (1,4-alpha-D- 
MKKFLKMTAAFSLGLSLAFGLFSPAQAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGTCTNLRLYCGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYSIINYSGVN
NTAYHGYWARDFKKTNPAYGTIADFQNLIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAE
NGRLYDNGTLLGGYTNDTQNLFHHNGGTDFSTTENGIYKNLYDLADLNHNNSTSDVYLKD
AIKMWLDLGIDGIRMDAVKHMPFGWQKSFMAAVNNYKPVFTFGEWFLGVNEVGPENHKFA
NESGMSLLDFRFAQKVRQVFRDNTDNMYGLKAMLEGSAADYAQVDDQVTFIDNHDMERFH
ASNANRRKLEQALAFTLILARVPAIYYGTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQK
LAPLRKSNPAIAYGSTQERWINNDVLIYERKFGSNVAVVAVNRNLNAPASISGLVTSLPQ
GSYNDVLGGLLNGNTLTVGSGGAASNFTLAAGGTAVWQYTAATATPTIGHVGPMMAKPGV
TITIDGRGFGSSKGTVYFGTTAVSGANITSWEDTQIKVKIPAVAGGIYNIKVANAAGTAS
NVYDNFEVLSGDQVSVRFVVNNATTALGQNLYLTGNVSELGNWDPAKAIGPMYNQVVYQY
PNWYYDVSVPAGKTIEFKFLKKQGSTVTWEGGSNHTFTAPSSGTATINVNWQP
>sp|Q06848|ANCA_CLOTM Cellulosome anchoring protein precursor. 
MKRIKRILAVLTIFALLATINAFTFVSLAQTNTIEIIIGNVKARPGDRIEVPVSLKNVPD
KGIVSSDFVIEYDSKLFKVIELKAGDIVENPSESFSYNVVEKDEIIAVLYLEETGLGIEA
IRTDGVFFTIVMEVSKDVKPGISPIKFESFGATADNDMNEMTPKLVEGKVEIIEASAPEA
TPTPGSTAGSGAGGGTGSSGSGQPSATPTPTATEKPSTTPKTTEQPHEDIPQSGGTGEHA
PFLKGYPGGLFKPENNITRAEAAVIFAKLLGADENSAGKNSSITFKDLKDSHWAAWAIKY
VTEQNLFGGYPDGTFMPDKSITRAEFATVTYKFLEKLGKIEQGTDVKTQLKDIEGHWAQK
YIETLVAKGYIKGYPDETFRPQASIKRAESVALINRSLERGPLNGAVLEFTDVPVNYWAY
KDIAEGVIYHSYKIDENGQEVMVEKLD
>sp|P15636|API_ACHLY Protease I precursor (EC 3.4.21.50) (API) (Lysyl endopeptidase). 
MKRICGSLLLLGLSISAALAAPASRPAAFDYANLSSVDKVALRTMPAVDVAKAKAEDLQR
DKRGDIPRFALAIDVDMTPQNSGAWEYTADGQFAVWRQRVRSEKALSLNFGFTDYYMPAG
GRLLVYPATQAPAGDRGLISQYDASNNNSARQLWTAVVPGAEAVIEAVIPRDKVGEFKLR
LTKVNHDYVGFGPLARRLAAASGEKGVSGSCNIDVVCPEGDGRRDIIRAVGAYSKSGTLA
CTGSLVNNTANDRKMYFLTAHHCGMGTASTAASIVVYWNYQNSTCRAPNTPASGANGDGS
MSQTQSGSTVKATYATSDFTLLELNNAANPAFNLFWAGWDRRDQNYPGAIAIHHPNVAEK
RISNSTSPTSFVAWGGGAGTTHLNVQWQPSGGVTEPGSSGSPIYSPEKRVLGQLHGGPSS
CSATGTNRSDQYGRVFTSWTGGGAAASRLSDWLDPASTGAQFIDGLDSGGGTPNTPPVAN
FTSTTSGLTATFTDSSTDSDGSIASRSWNFGDGSTSTATNPSKTYAAAGTYTVTLTVTDN
GGATNTKTGSVTVSGGPGAQTYTNDTDVAIPDNATVESPITVSGRTGNGSATTPIQVTIY
HTYKSDLKVDLVAPDGTVYNLHNRTGGSAHNIIQTFTKDLSSEAAQRAPGSCG
>sp|P13276|APL3_MANSE Apolipophorin-III precursor (APOLP-III). 
MAAKFVVVLAACVALSHSAMVRRDAPAGGNAFEEMEKHAKEFQKTFSEQFNSLVNSKNTQ
DFNKALKDGSDSVLQQLSAFSSSLQGAISDANGKAKEALEQARQNVEKTAEELRKAHPDV
EKEANAFKDKLQAAVQTTVQESQKLAKEVASNMEETNKKLAPKIKQAYDDFVKHAEEVQK
KLHEAATKQ
>sp|P08594|AQL1_THEAQ Aqualysin I precursor (EC 3.4.21.-). 
MRKTYWLMALFAVLVLGGCQMASRSDPTPTLAEAFWPKEAPVYGLDDPEAIPGRYIVVFK
KGKGQSLLQGGITTLQARLAPQGVVVTQAYTGALQGFAAEMAPQALEAFRQSPDVEFIEA
DKVVRAWATQSPAPWGLDRIDQRDLPLSNSYTYTATGRGVNVYVIDTGIRTTHREFGGRA
RVGYDALGGNGQDCNGHGTHVAGTIGGVTYGVAKAVNLYAVRVLDCNGSGSTSGVIAGVD
WVTRNHRRPAVANMSLGGGVSTALDNAVKNSIAAGVVYAVAAGNDNANACNYSPARVAEA
LTVGATTSSDARASFSNYGSCVDLFAPGASIPSAWYTSDTATQTLNGTSMATPHVAGVAA
LYLEQNPSATPASVASAILNGATTGRLSGIGSGSPNRLLYSLLSSGSGSTAPCTSCSYYT
GSLSGPGDYNFQPNGTYYYSPAGTHRAWLRGPAGTDFDLYLWRWDGSRWLTVGSSTGPTS
EESLSYSGTAGYYLWRIYAYSGSGMYEFWLQRP
>sp|P24020|AQN3_PIG Carbohydrate-binding protein AQN-3 (Zona pellucida-binding protein 
AQNKGSDDCGGFLKNYSGWISYYKALTTNCVWTIEMKPGHKIILQILPLNLTCGKEYLEV
RDQRAGPDNFLKVCGGTGFVYQSSHNVATVKYSRDSHHPASSFNVYFYGIPQGAKA
>sp|Q04732|ARP_EUGGR Calcium-binding acidic-repeat protein precursor (ARP). 
MSHLWCWLFLVLCLACLVLSIEAKDSDGDGLLDVDEINVYFTDPYNADSDQDGLTDGLEV
NRHQTHPQDKDTDDDSIGDGVEVNNLGTNPKDPDSDDDGLTDGAEVNLYRTDPLDADSTT
TGCPMGGGAEVRHRPQNGDTDDDGLTDGAEVNVHRTNPQDGDSDDDGLSDGAEVNTYHSN
PKDGDSDDDGVSDGAEVNPKLKDSDGDGLTDEEEIKLYRTDPFCADSDFDGLLDGEEVKV
HKTNPLDGDSDDDGLGDGAEVTHFNTNPLDADSDNDGLDDGEEINVHGTDPEDPDSDNDG
LNDGDEVNVYNTDPEEDDSDEDGVCDGAEVNVHHTNPKDEDSDNDGIPDGAEINTHKTDP
NDEDSDDDGIADGAEVTLTDSDGDGLPDEDEVALYNTNPANADSDYDGLTDGAEVKRYQS
NPLDKDTDDDGLGDGVEVTVGTDPHDATVTTTGSRTAVEINVHGSDPNDEDTDDDGLTDG
AEVNLHRTDPEDADTDDDGLTDGAEVNTYRTNPKLADSDGDGLSDGAEVNTHKSDPNDGD
SDDDGVPDAAEAKVKDSDGDGLSDTDEVRFRTNPKLADTDFDGLTDGAEILKHKTDPRNR
DTDGDGVADGLEVNTYGSDPKDADTDDDGLTDGAEINVHDTNPTDADSDDDGLSDGAEVM
TYHTNAKDGDSDDDGKADGAEVSASTDPWRSDHSV
>sp|P28514|ARY2_CALVI Arylphorin subunit C223 precursor. 
MKIAIVLLAIVGLAASASITDKKVKIADKDFLAKQKFLFEIVYRVEDPLMFEEWIKMGKS
FTFDKADYNHFDMYMDKFYEAYKYGAILPKGEFFYYAKNWEVFQRNVAFARMHCNEGMFV
YALTLAVIHRDDFHGLILPSIYEIFPQYFFNSKFVYEAEKFDYDVWSKYIMYEKEYKDIL
YKDYATFYKNHDNHYYYFFTKDFKTYQWWKMMGLGEHWYSEDRFMLRDNMDKYNKDSKYL
EIFEGTKMFFMPVDYTRDIEFFNKESALSYFTEDVGFNAYWYYLNMDYAFFLDGKTYGLN
KDRRGEYWLYNVRQLLSRYYMERLSHGFGEIPAFSFIDSIEYGYNPQLVYHNGVGFSYRK
NYYEVESFGKFDYFYKVLDFFNRMDEIITKGVYVTYDGKTIDLRKPESIEYIGSIMQGNV
DTLHSYFFKYWYMFAHMYLAYDNTQTLQVFPHIFLNYETSMRDPMFYMFYKKIASVYFQF
FNYVKPYTHEELLFPGVTIKDVKVSELVTYFDLVDFDVTNLMNDKMTFVDGQFVWDKTLL
ARQMRLNHKPFDFDFVIESDKAQKVVIRTYLGPKYDEFGRVISLTENRENFMELDSFLYT
LKSGVNEFKRYSKDFYWTVEDRTTYTELYKYVMLALQGKYDFPLDISEPHCGFPDRLVLP
HGWYKGMPMQFFFYVTPFTTEYEQFSTYDYSYSCGLGSGVRYIDETCFGYPFDREIDEYE
FFVPNMYFKDVKIFHQDTFEKYFEHKYEKFGHFDYNYHH
>sp|P18840|ASG1_ECOLI L-asparaginase I (EC 3.5.1.1) (L-asparagine amidohydrolase I) 
MQKKSIYVAYTGGTIGMQRSEQGYIPVSGHLQRQLALMPEFHRPEMPDFTIHEYTPLMDS
SDMTPEDWQHIAEDIKAHYDDYDGFVILHGTDTMAYTASALSFMLENLGKPVIVTGSQIP
LAELRSDGQINLLNALYVAANYPINEVTLFFNNRLYRGNRTTKAHADGFDAFASPNLPPL
LEAGIHIRRLNTPPAPHGEGELIVHPITPQPIGVVTIYPGISADVVRNFLRQPVKALILR
SYGVGNAPQNKAFLQELQEASDRGIVVVNLTQCMSGKVNMGGYATGNALAHAGVIGGADM
TVEATLTKLHYLLSQELDTETIRKAMSQNLRGELTPDD
>sp|P00805|ASG2_ECOLI L-asparaginase II precursor (EC 3.5.1.1) (L-asparagine 
MEFFKKTALAALVMGFSGAALALPNITILATGGTIAGGGDSATKSNYTVGKVGVENLVNA
VPQLKDIANVKGEQVVNIGSQDMNDNVWLTLAKKINTDCDKTDGFVITHGTDTMEETAYF
LDLTVKCDKPVVMVGAMRPSTSMSADGPFNLYNAVVTAADKASANRGVLVVMNDTVLDGR
DVTKTNTTDVATFKSVNYGPLGYIHNGKIDYQRTPARKHTSDTPFDVSKLNELPKVGIVY
NYANASDLPAKALVDAGYDGIVSAGVGNGNLYKSVFDTLATAAKTGTAVVRSSRVPTGAT
TQDAEVDDAKYGFVASGTLNPQKARVLLQLALTQTKDPQQIQQIFNQY
>sp|P22063|AXO1_RAT Contactin 2 precursor (Axonin-1) (Axonal glycoprotein TAG-1) 
MGTHARKKASLLLLVLATVALVSSPGWSFAQGTPATFGPIFEEQPIGLLFPEESAEDQVT
LACRARASPPATYRWKMNGTDMNLEPGSRHQLMGGNLVIMSPTKTQDAGVYQCLASNPVG
TVVSKEAVLRFGFLQEFSKEERDPVKTHEGWGVMLPCNPPAHYPGLSYRWLLNEFPNFIP
TDGRHFVSQTTGNLYIARTNASDLGNYSCLATSHMDFSTKSVFSKFAQLNLAAEDPRLFA
PSIKARFPPETYALVGQQVTLECFAFGNPVPRIKWRKVDGSLSPQWATAEPTLQIPSVSF
EDEGTYECEAENSKGRDTVQGRIIVQAQPEWLKVISDTEADIGSNLRWGCAAAGKPRPMV
RWLRNGEPLASQNRVEVLAGDLRFSKLSLEDSGMYQCVAENKHGTIYASAELAVQALAPD
FRQNPVRRLIPAARGGEISILCQPRAAPKATILWSKGTEILGNSTRVTVTSDGTLIIRNI
SRSDEGKYTCFAENFMGKANSTGILSVRDATKITLAPSSADINVGDNLTLQCHASHDPTM
DLTFTWTLDDFPIDFDKPGGHYRRASAKETIGDLTILNAHVRHGGKYTCMAQTVVDGTSK
EATVLVRGPPGPPGGVVVRDIGDTTVQLSWSRGFDNHSPIAKYTLQARTPPSGKWKQVRT
NPVNIEGNAETAQVLGLMPWMDYEFRVSASNILGTGEPSGPSSKIRTKEAVPSVAPSGLS
GGGGAPGELIINWTPVSREYQNGDGFGYLLSFRRQGSSSWQTARVPGADAQYFVYGNDSI
QPYTPFEVKIRSYNRRGDGPESLTALVYSAEEEPRVAPAKVWAKGSSSSEMNVSWEPVLQ
DMNGILLGYEIRYWKAGDNEAAADRVRTAGLDTSARVTGLNPNTKYHVTVRAYNRAGTGP
ASPSADAMTVKPPPRRPPGNISWTFSSSSLSLKWDPVVPLRNESTVTGYKMLYQNDLHPT
PTLHLTSKNWIEIPVPEDIGHALVQIRTTGPGGDGIPAEVHIVRNGGTSMMVESAAARPA
HPGPAFSCMVILMLAGYQKL
>sp|P10424|BLA1_BACCE Beta-lactamase, type I precursor (EC 3.5.2.6) (Penicillinase). 
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRA
GVPTDWVDADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>sp|P35804|BLIP_STRCL Beta-lactamase inhibitory protein precursor (BLIP). 
MRTVGIGAGVRRLGRAVVMAAAVGGLVLGSAGASNAAGVMTGAKFTQIQFGMTRQQVLDI
AGAENCETGGSFGDSIHCRGHAAGDYYAYATFGFTSAAADAKVDSKSQEKLLAPSAPTLT
LAKFNQVTVGMTRAQVLATVGQGSCTTWSEYYPAYPSTAGVTLSLSCFDVDGYSSTGFYR
GSAHLWFTDGVLQGKRQWDLV
>sp|P40835|BR1A_RANES Brevinin-1EA. 
FLPAIFRMAAKVVPTIICSITKKC
>sp|P40837|BR2A_RANES Brevinin-2EA. 
GILDTLKNLAISAAKGAAQGLVNKASCKLSGQC
>sp|P28027|BRA2_CHITH Balbiani ring A 28 kDa protein precursor. 
MKSIIKHILFVVLLISIIHDSQCRWFILKNRLSHFINRISELKEQDSREAKLYKSFDIDC
GKNFLKVQQNSKMLVNEEEELVFKVASSLKCSSEDAAFKFYFDEIIRPKLKKGLSCFELH
LQQQEPDSKLIKNAIITKAEVEKCKKQSPIDDLKEVENGLEDVIGPLDVFSCGAVTSVDD
YVLFVTKSVLIKFGESSEAVKKVEMEKLKEYLKDIAFTTAECIFKRFETDPKGTWFIFVG
YVARF
>sp|P40841|BREE_RANES Brevinin-2EE. 
GIFDKLKNFAKGVAQSLLNKASCKLSGQC
>sp|P26726|BXA3_BOMMO Bombyxin A-3 precursor (BBX-A3) (4K-prothoracicotropic hormone) 
MKILLAIALMLSTVMWVSTQQPQGVHTYCGRHLARTLANLCWEAGVDKRSDAQYVSYGSA
WLMPYSEGRGKRGIVDECCLRPCSVDVLLSYC
>sp|P26735|BXC2_BOMMO Bombyxin C-2 precursor (BBX-C2) (4K-prothoracicotropic hormone) 
MKLVILLVVVSAMLVLGGAQTASQFYCGDFLARTMSILCWPDMPKRSGSQYAGYGWPWLP
PFSSSRGKRGIVDECCYRPCTTDVLKLYCDKQITI
>sp|P30996|BXF_CLOBO Botulinum neurotoxin type F precursor (EC 3.4.24.69) (BoNT/F) 
MPVAINSFNYNDPVNDDTILYMQIPYEEKSKKYYKAFEIMRNVWIIPERNTIGTNPSDFD
PPASLKNGSSAYYDPNYLTTDAEKDRYLKTTIKLFKRINSNPAGKVLLQEISYAKPYLGN
DHTPIDEFSPVTRTTSVNIKLSTNVESSMLLNLLVLGAGPDIFESCCYPVRKLIDPDVVY
DPSNYGFGSINIVTFSPEYEYTFNDISGGHNSSTESFIADPAISLAHELIHALHGLYGAR
GVTYEETIEVKQAPLMIAEKPIRLEEFLTFGGQDLNIITSAMKEKIYNNLLANYEKIATR
LSEVNSAPPEYDINEYKDYFQWKYGLDKNADGSYTVNENKFNEIYKKLYSFTESDLANKF
KVKCRNTYFIKYEFLKVPNLLDDDIYTVSEGFNIGNLAVNNRGQSIKLNPKIIDSIPDKG
LVEKIVKFCKSVIPRKGTKAPPRLCIRVNNSELFFVASESSYNENDINTPKEIDDTTNLN
NNYRNNLDEVILDYNSQTIPQISNRTLNTLVQDNSYVPRYDSNGTSEIEEYDVVDFNVFF
YLHAQKVPEGETNISLTSSIDTALLEESKDIFFSSEFIDTINKPVNAALFIDWISKVIRD
FTTEATQKSTVDKIADISLIVPYVGLALNIIIEAEKGNFEEAFELLGVGILLEFVPELTI
PVILVFTIKSYIDSYENKNKAIKAINNSLIEREAKWKEIYSWIVSNWLTRINTQFNKRKE
QMYQALQNQVDAIKTAIEYKYNNYTSDEKNRLESEYNINNIEEELNKKVSLAMKNIERFM
TESSISYLMKLINEAKVGKLKKYDNHVKSDLLNYILDHRSILGEQTNELSDLVTSTLNSS
IPFELSSYTNDKILIIYFNRLYKKIKDSSILDMRYENNKFIDISGYGSNISINGNVYIYS
TNRNQFGIYNSRLSEVNIAQNNDIIYNSRYQNFSISFWVRIPKHYKPMNHNREYTIINCM
GNNNSGWKISLRTVRDCEIIWTLQDTSGNKENLIFRYEELNRISNYINKWIFVTITNNRL
GNSRIYINGNLIVEKSISNLGDIHVSDNILFKIVGCDDETYVGIRYFKVFNTELDKTEIE
TLYSNEPDPSILKNYWGNYLLYNKKYYLFNLLRKDKYITLNSGILNINQQRGVTEGSVFL
NYKLYEGVEVIIRKNGPIDISNTDNFVRKNDLAYINVVDRGVEYRLYADTKSEKEKIIRT
SNLNDSLGQIIVMDSIGNNCTMNFQNNNGSNIGLLGFHSNNLVASSWYYNNIRRNTSSNG
CFWSSISKENGWKE
>sp|P20851|C4BB_HUMAN C4b-binding protein beta chain precursor. 
MFFWCACCLMVAWRVSASDAEHCPELPPVDNSIFVAKEVEGQILGTYVCIKGYHLVGKKT
LFCNASKEWDNTTTECRLGHCPDPVLVNGEFSSSGPVNVSDKITFMCNDHYILKGSNRSQ
CLEDHTWAPPFPICKSRDCDPPGNPVHGYFEGNNFTLGSTISYYCEDRYYLVGVQEQQCV
DGEWSSALPVCKLIQEAPKPECEKALLAFQESKNLCEAMENFMQQLKESGMTMEELKYSL
ELKKAELKAKLL
>sp|P08572|CA24_HUMAN Collagen alpha 2(IV) chain precursor. 
MGRDQRAVAGPALRRWLLLGTVTVGFLAQSVLAGVKKFDVPCGGRDCSGGCQCYPEKGGR
GQPGPVGPQGYNGPPGLQGFPGLQGRKGDKGERGAPGVTGPKGDVGARGVSGFPGADGIP
GHPGQGGPRGRPGYDGCNGTQGDSGPQGPPGSEGFTGPPGPQGPKGQKGEPYALPKEERD
RYRGEPGEPGLVGFQGPPGRPGHVGQMGPVGAPGRPGPPGPPGPKGQQGNRGLGFYGVKG
EKGDVGQPGPNGIPSDTLHPIIAPTGVTFHPDQYKGEKGSEGEPGIRGISLKGEEGIMGF
PGLRGYPGLSGEKGSPGQKGSRGLDGYQGPDGPRGPKGEAGDPGPPGLPAYSPHPSLAKG
ARGDPGFPGAQGEPGSQGEPGDPGLPGPPGLSIGDGDQRRGLPGEMGPKGFIGDPGIPAL
YGGPPGPDGKRGPPGPPGLPGPPGPDGFLFGLKGAKGRAGFPGLPGSPGARGPKGWKGDA
GECRCTEGDEAIKGLPGLPGPKGFAGINGEPGRKGDKGDPGQHGLPGFPGLKGVPGNIGA
PGPKGAKGDSRTITTKGERGQPGVPGVPGMKGDDGSPGRDGLDGFPGLPGPPGDGIKGPP
GDPGYPGIPGTKGTPGEMGPPGLGLPGLKGQRGFPGDAGLPGPPGFLGPPGPAGTPGQID
CDTDVKRAVGGDRQEAIQPGCIAGPKGLPGLPGPPGPTGAKGLRGIPGFAGADGGPGPRG
LPGDAGREGFPGPPGFIGPRGSKGAVGLPGPDGSPGPIGLPGPDGPPGERGLPGEVLGAQ
PGPRGDAGVPGQPGLKGLPGDRGPPGFRGSQGMPGMPGLKGQPGLPGPSGQPGLYGPPGL
HGFPGAPGQEGPLGLPGIPGREGLPGDRGDPGDTGAPGPVGMKGLSGDRGDAGFTGEQGH
PGSPGFKGIDGMPGTPGLKGDRGSPGMDGFQGMPGLKGRPGFPGSKGEAGFFGIPGLKGL
AGEPGFKGSRGDPGPPGPPPVILPGMKDIKGEKGDEGPMGLKGYLGAKGIQGMPGIPGLS
GIPGLPGRPGHIKGVKGDIGVPGIPGLPGFPGVAGPPGITGFPGFIGSRGDKGAPGRAGL
YGEIGATGDFGDIGDTINLPGRPGLKGERGTTGIPGLKGFFGEKGTEGDIGFPGITGVTG
VQGPPGLKGQTGFPGLTGPPGSQGELGRIGLPGGKGDDGWPGAPGLPGFPGLRGIRGLHG
LPGTKGFPGSPGSDIHGDPGFPGPPGERGDPGEANTLPGPVGVPGQKGDQGAPGERGPPG
SPGLQGFPGITPPSNISGAPGDKGAPGIFGLKGYRGPPGPPGSAALPGSKGDTGNPGAPG
TPGTKGWAGDSGPQGRPGVFGLPGEKGPRGEQGFMGNTGPTGAVGDRGPKGPKGDPGFPG
APGTVGAPGIAGIPQKIAIQPGTVGPQGRRGPPGAPGEIGPQGPPGEPGFRGAPGKAGPQ
GRGGVSAVPGFRGDEGPIGHQGPIGQEGAPGRPGSPGLPGMPGRSVSIGYLLVKHSQTDQ
EPMCPVGMNKLWSGYSLLYFEGQEKAHNQDLGLAGSCLARFSTMPFLYCNPGDVCYYASR
NDKSYWLSTTAPLPMMPVAEDEIKPYISRCSVCEAPAIAIAVHSQDVSIPHCPAGWRSLW
IGYSFLMHTAAGDEGGGQSLVSPGSCLEDFRATPFIECNGGRGTCHYYANKYSFWLTTIP
EQSFQGSPSADTLKAGLIRTHISRCQVCMKNL
>sp|P32017|CA39_CHICK Collagen alpha 3(IX) chain precursor. 
MTVFPTLGLLFLCQLLATTSAQRVGPQGPPGPRGPPGPSGKDGIDGEPGPSGLPGPPGPK
GAPGKPGAAGEAGLPGLPGVDGLTGTDGPPGPNGPPGDRGALGPAGPPGPAGKGLPGPPG
PPGPSGLPGGNGFRGPPGPSGLPGFPGPPGPPGPPGLAGIIPEGGGDLQCPALCPPGPPG
PPGMPGFKGHTGHKGGPGEIGKEGEKGSPGPPGPPGIPGSVGLQGPRGLRGLPGPMGPAG
DRGDIGFRGPPGIPGPPGRAGDQGNKGPQGFRGPKGDTGRPGPKGNPGARGLIGEPGIPG
KDGRDGAPGLDGEKGDAARMGVPGEKGPNGLPGLPGRAGIKGSKGEPGSPGEMGEAGPSG
EPGIPGDVGIPGDRGLPGPRGATGPVGLPGPIGAPGVRGFQGPKGSSGEPGLPGPTGIRG
ESGDRGPAGVIGAKGSQGIAGADGLPGDKGELGPFGPPGQKGEPGKRGELGPKGAQGPNG
TAGAPGIPGHPGPMGHQGEQGVPGITGKPGPPGKEASEQHIRELCGEMINDQIAQLAANL
RKPLSPGMTGRPGPAGPPGPPGATGSVGHPGARGPPGYRGPTGELGDPGPRGDTGEKGDK
GPAGQGIDGPDGDQGPQGLPGVPGISKNGRDGAQGEPGLPGDPGTPGAVGAQGTPGICDT
SACMGAVGASTSKKS
>sp|P29400|CA54_HUMAN Collagen alpha 5(IV) chain precursor. 
MKLRGVSLAAGLFLLALSLWGQPAEAAACYGCSPGSKCDCSGIKGEKGERGFPGLEGHPG
LPGFPGPEGPPGPRGQKGDDGIPGPPGPKGIRGPPGLPGFPGTPGLPGMPGHDGAPGPQG
IPGCNGTKGERGFPGSPGFPGLQGPPGPPGIPGMKGEPGSIIMSSLPGPKGNPGYPGPPG
IQGLPGPTGIPGPIGPPGPPGLMGPPGPPGLPGPKGNMGLNFQGPKGEKGEQGLQGPPGP
PGQISEQKRPIDVEFQKGDQGLPGDRGPPGPPGIRGPPGPPGGEKGEKGEQGEPGKRGKP
GKDGENGQPGIPGLPGDPGYPGEPGRDGEKGQKGDTGPPGPPGLVIPRPGTGITIGEKGN
IGLPGLPGEKGERGFPGIQGPPGLPGPPGAAVMGPPGPPGFPGERGQKGDEGPPGISIPG
PPGLDGQPGAPGLPGPPGPAGPHIPPSDEICEPGPPGPPGSPGDKGLQGEQGVKGDKGDT
CFNCIGTGISGPPGQPGLPGLPGPPGSLGFPGQKGEKGQAGATGPKGLPGIPGAPGAPGF
PGSKGEPGDILTFPGMKGDKGELGSPGAPGLPGLPGTPGQDGLPGLPGPKGEPGGITFKG
ERGPPGNPGLPGLPGNIGPMGPPGFGPPGPVGEKGIQGVAGNPGQPGIPGPKGDPGQTIT
QPGKPGLPGNPGRDGDVGLPGDPGLPGQPGLPGIPGSKGEPGIPGIGLPGPPGPKGFPGI
PGPPGAPGTPGRIGLEGPPGPPGFPGPKGEPGFALPGPPGPPGLPGFKGALGPKGDRGFP
GPPGPPGRTGLDGLPGPKGDVGPNGQPGPMGPPGLPGIGVQGPPGPPGIPGPIGQPGLHG
IPGEKGDPGPPGLDVPGPPGERGSPGIPGAPGPIGPPGSPGLPGKAGASGFPGTKGEMGM
MGPPGPPGPLGIPGRSGVPGLKGDDGLQGQPGLPGPTGEKGSKGEPGLPGPPGPMDPNLL
GSKGEKGEPGLPGIPGVSGPKGYQGLPGDPGQPGLSGQPGLPGPPGPKGNPGLPGQPGLI
GPPGLKGTIGDMGFPGPQGVEGPPGPSGVPGQPGSPGLPGQKGDKGDPGISSIGLPGLPG
PKGEPGLPGYPGNPGIKGSVGDPGLPGLPGTPGAKGQPGLPGFPGTPGPPGPKGISGPPG
NPGLPGEPGPVGGGGHPGQPGPPGEKGKPGQDGIPGPAGQKGEPGQPGFGNPGPPGLPGL
SGQKGDGGLPGIPGNPGLPGPKGEPGFHGFPGVQGPPGPPGSPGPALEGPKGNPGPQGPP
GRPGLPGPEGPPGLPGNGGIKGEKGNPGQPGLPGLPGLKGDQGPPGLQGNPGRPGLNGMK
GDPGLPGVPGFPGMKGPSGVPGSAGPEGEPGLIGPPGPPGLPGPSGQSIIIKGDAGPPGI
PGQPGLKGLPGPQGPQGLPGPTGPPGDPGRNGLPGFDGAGGRKGDPGLPGQPGTRGLDGP
PGPDGLQGPPGPPGTSSVAHGFLITRHSQTTDAPQCPQGTLQVYEGFSLLYVQGNKRAHG
QDLGTAGSCLRRFSTMPFMFCNINNVCNFASRNDYSYWLSTPEPMPMSMQPLKGQSIQPF
ISRCAVCEAPAVVIAVHSQTIQIPHCPQGWDSLWIGYSFMMHTSAGAEGSGQALASPGSC
LEEFRSAPFIECHGRGTCNYYANSYSFWLATVDVSDMFSKPQSETLKAGDLRTRISRCQV
CMKRT
>sp|P05805|CAC3_BOVIN Proproteinase E precursor (Procarboxypeptidase A complex component 
FSQPFSRPSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCIST
SRTYQVVLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGD
KVQLANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPVVDYEHCSQWDWWGIT
VKKTMVCAGGDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVS
AFIDWIDETIASN
>sp|P08060|CAH6_SHEEP Carbonic anhydrase VI (EC 4.2.1.1) (Carbonate dehydratase VI) (CA-VI) 
GHGVEWTYSEGMLDEAHWPLEYPKCGGRRQSPIDLQMKKVQYNPSLRALNLTGYGLWHGE
FPVTNNGHTVQISLPSTMSMTTSDGTQYLAKQMHFHWGGASSEISGSEHTVDGMRYVIEI
HVVHYNSKYNSYEEAQKEPDGLAVLAALVEVKDYTENAYYSKFISHLEDIRYAGQSTVLR
GLDIEDMLPGDLRYYYSYLGSLTTPPCTENVHWFVVADTVKLSKTQVEKLENSLLNHQNK
TIQNDYRRTQPLNHRVVEANFMSRPHQEYTLASKLHFYLNNIDQTLEYLRRFIEQKIPKR
KKQENWP
>sp|P15156|CASP_MESAU Calcium-dependent serine proteinase precursor (EC 3.4.21.-) (CASP). 
MGKSSEAWCIVLFSVFASFSAEPTMHGEILSPNYPQAYPNEMEKTWDIEVPEGFGVRLYF
THLDMELSENCEYDSVQIISGGVEEGRLCGQRTSKNANSPIVEEFQIPYNKLQVIFRSDF
SNEERFTGFAAYYAAIDVNECTDFTDVPCSHFCNNFIGGYFCSCPPEYFLHDDMRNCGVN
CSGNVFTALIGEISSPNYPNPYPENSRCEYQILLEEGFQVVVTIQREDFDVEPADSQGNC
QDSLLFAAKNRQFGPFCGNGFPGPLTIETHSNTLDIVFQTDLTEQKKGWKLRYHGDPIPC
PKEITANSVWAPEKAKYVFKDVVKISCVDGFEAVEGNVGSTFFYSTCQSNGQWSNSRLRC
QPVDCGIPEPIQNGKVDDPENTLFGSVIHYSCEEPYYYMEHAEHGGEYRCAANGSWVNDE
LGIELPKCVPVCGVPTEPFRIQQRIFGGFPAKIQSFPWQVFFEFPRAGGALIGEHWVLTA
AHVVEGNSDPSMYVGSTSVRMENLANVQKLTTDRVIIHPGWKPGDDLSTRTNFDNDIALV
RLKDPVKMGPTVSPICLPGTSSEYEPSEGDLGLISGWGRTERRNIVIQLRGAKLPVTSLE
KCRQVKEENPKARADDYVFTSNMICAGEKGVDSCQGDSGGAFALPVPNVRDPKFYVAGLV
SWGKKCGTYGIYTKVKNYKDWILQTMQENSVPSQD
>sp|P38578|CBA_CARPI Bacteriocin carnobacteriocin A precursor (Piscicolin 61). 
MNNVKELSIKEMQQVTGGDQMSDGVNYGKGSSLSKGGAKCGLGIVGGLATIPSGPLGWLA
GAAGVINSCMK
>sp|P38579|CBB1_CARPI Bacteriocin carnobacteriocin BM1 precursor (Carnobacteriocin B1). 
MKSVKELNKKEMQQINGGAISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMG
H
>sp|P23775|CBG_RABIT Corticosteroid-binding globulin (CBG) (Transcortin). 
ADPPGGDISTRSPPRGLAPANVDFAFSLYRQLVSSAPDRNICISPVSVSMALAMLSLGAS
GHTRTQLLQGLGFNLTEMPEAEIHQGFQYLHHLLGESDTSLEMTMGNALFLDHSLELLES
FSADIRRYYESEALATDFQDWPRACRQINEYIENKTQGKIADLFLGLENPAILILVNYIF
FKGTWAHPFDPQSTEEKSFYVDDTTTVMVPMMFQSSTVKYLHDPVLPCRLVQLDYVGNGT
AFFILPDKGKVDTVIAALSRDTIQRWSKSLTYRLVHLYIPKASISGAYELRGALAAMGIA
DLFTNQANFSSISQEGPLKVSKVLHKAVLQLDEHGGVEVAATGGPLQLVSEPLTLNFNRP
FLILIFDDFTWSSLFLGKVVIPA
>sp|P04830|CDG1_PAEMA Cyclomaltodextrin glucanotransferase precursor (EC 2.4.1.19) 
MKSRYKRLTSLALSLSMALGISLPAWASPDTSVDNKVNFSTDVIYQIVTDRFADGDRTNN
PAGDAFSGDRSNLKLYFGGDWQGIIDKINDGYLTGMGVTALWISQPVENITSVIKYSGVN
NTSYHGYWARDFKQTNDAFGDFADFQNLIDTAHAHNIKVVIDFAPNHTSPADRDNPGFAE
NGGMYDNGSLLGAYSNDTAGLFHHNGGTDFSTIEDGIYKNLYDLADINHNNNAMDAYFKS
AIDLWLGMGVDGIRFDAVKHMPFGWQKSFVSSIYGGDHPVFTFGEWYLGADQTDGDNIKF
ANESGMNLLDFEYAQEVREVFRDKTETMKDLYEVLASTESQYDYINNMVTFIDNHDMDRF
QVAGSGTRATEQALALTLTSRGVPAIYYGTEQYMTGDGDPNNRAMMTSFNTGTTAYKVIQ
ALAPLRKSNPAIAYGTTTERWVNNDVLIIERKFGSSAALVAINRNSSAAYPISGLLSSLP
AGTYSDVLNGLLNGNSITVGSGGAVTNFTLAAGGTAVWQYTAPETSPAIGNVGPTMGQPG
NIVTIDGRGFGGTAGTVYFGTTAVTGSGIVSWEDTQIKAVIPKVAAGKTGVSVKTSSGTA
SNTFKSFNVLTGDQVTVRFLVNQANTNYGTNVYLVGNAAELGSWDPNKAIGPMYNQVIAK
YPSWYYDVSVPAGTKLDFKFIKKGGGTVTWEGGGNHTYTTPASGVGTVTVDWQN
>sp|P22522|CEAV_ECOLI Colicin V precursor (Microcin V bacteriocin). 
MRTLTLNELDSVSGGASGRDIAMAIGTLSGQFVAGGIGAAAGGVAGGAIYDYASTHKPNP
AMSPSGLGGTIKQKPEGIPSEAWNYAAGRLCNWSPNNLSDVCL
>sp|Q03591|FHR1_HUMAN Complement factor H-related protein 1 precursor (FHR-1) (H factor-like 
MWLLVSVILISRISSVGGEATFCDFPKINHGILYDEEKYKPFSQVPTGEVFYYSCEYNFV
SPSKSFWTRITCTEEGWSPTPKCLRLCFFPFVENGHSESSGQTHLEGDTVQIICNTGYRL
QNNENNISCVERGWSTPPKCRSTDTSCVNPPTVQNAYIVSRQMSKYPSGERVRYQCRSPY
EMFGDEEVMCLNGNWTEPPQCKDSTGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNL
YQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWTAKQKLYLRTGESAEFVC
KRGYRLSSRSHTLRTTCWDGKLEYPTCAKR
>sp|Q02985|FHR3_HUMAN Complement factor H-related protein 3 precursor (FHR-3) (H factor-like 
MLLLINVILTLWVSCANGQVKPCDFPDIKHGGLFHENMRRPYFPVAVGKYYSYYCDEHFE
TPSGSYWDYIHCTQNGWSPAVPCLRKCYFPYLENGYNQNYGRKFVQGNSTEVACHPGYGL
PKAQTTVTCTEKGWSPTPRCIRVRTCSKSDIEIENGFISESSSIYILNKEIQYKCKPGYA
TADGNSSGSITCLQNGWSAQPICINSSEKCGPPPPISNGDTTSFLLKVYVPQSRVEYQCQ
PYYELQGSNYVTCSNGEWSEPPRCIHPCIITEENMNKNNIKLKGRSDRKYYAKTGDTIEF
MCKLGYNANTSILSFQAVCREGIVEYPRCE
>sp|P10909|CLUS_HUMAN Clusterin precursor (Complement-associated protein SP-40,40) 
MMKTLLLFVGLLLTWESGQVLGDQTVSDNELQEMSNQGSKYVNKEIQNAVNGVKQIKTLI
EKTNEERKTLLSNLEEAKKKKEDALNETRESETKLKELPGVCNETMMALWEECKPCLKQT
CMKFYARVCRSGSGLVGRQLEEFLNQSSPFYFWMNGDRIDSLLENDRQQTHMLDVMQDHF
SRASSIIDELFQDRFFTREPQDTYHYLPFSLPHRRPHFFFPKSRIVRSLMPFSPYEPLNF
HAMFQPFLEMIHEAQQAMDIHFHSPAFQHPPTEFIREGDDDRTVCREIRHNSTGCLRMKD
QCDKCREILSVDCSTNNPSQAKLRRELDESLQVAERLTRKYNELLKSYQWKMLNTSSLLE
QLNEQFNWVSRLANLTQGEDQYYLRVTTVASHTSDSDVPSGVTEVVVKLFDSDPITVTVP
VEVSRKNPKFMETVAEKALQEYRKKHREE
>sp|P22323|COTR_CAVPO Contrapsin precursor (CP). 
MPSAISRGLLLLAGLCYLVFGIMAEDIQVAQVPSQHMPSHKVPRSLAHFAHSMHRVLTQQ
SNTSNIFFSPVSIATALAMVSLGAKGDTHTQILRSLEFNLTEIAEADIHDGFQNLLHTLN
RPHSEHQLTTGNGLFLDQNLKLKEKFSGDVKTLYHAEAFPTNFSNPKEAEKQINAYVEKG
TQGKIVDLVKDLGADTVLALVNYIFFRGKWEKPFDVKHTTQEDFHVDANTTVKVPMMKQQ
GMHKAFHCSTIQSWVLLLDYEGNVTALFLLPDEGKMQHLEETLTPELVFKFLRKTETMPA
YVSLPKLSISGTYDLKEVLRDLGITNVFSGAADLSGITEDMPLKISKGLHKALLTIDEEG
TEAAAATVLEATRTARPPRLSFNKPFFFLIIDHSTDTPLFVGKVMDPTKK
>sp|P80007|CRA2_HOMGA Crustacyanin A2 subunit. 
DGIPSFVTAGKCASVANQDNFDLRRYAGRWYQTHIIENAYQPVTRCIHSNYEYSTNDYGF
KVTTAGFNPNDEYLKIDFKVYPTKEFPAAHMLIDAPSVFAAPYEVIETDYETYSCVYSCI
TTDNYKSEFAFVFSRTPQTSGPAVEKTAAVFNKNGVEFSKFVPVSHTAECVYRA
>sp|P80029|CRC1_HOMGA Crustacyanin C1 subunit. 
DKIPDFVVPGKCASVDRNKLWAEQTPNRNSYAGVWYQFALTNNPYQLIEKCVRNEYSFDG
KQFVIKSTGIAYDGNLLKRNGKLYPNPFGEPHLSIDYENSFAAPLVILETDYSNYACLYS
CIDYNFGYHSDFSFIFSRSANLADQYVKKCEAAFKNINVDTTRFVKTVQGSSCPYDTQKT
L
>sp|P35220|CTNA_DROME Alpha-catenin. 
MLKPDKMGTLTDFGQIALKWDPKNLEIRTMSVEKTLEPLVLQVTTLVNTKGPSKKKKGKS
KRASALVAAVEKATENFIQKGEQIAYENPDITQEMLTAVDEVKKTGDAMSIAAREFSEDP
CSSLKRGNMVRAARNLLSAVTRLLILADMVDVHLLLKSLHIVEDDLNKLKNASSQDELMD
NMRQFGRNAGELIKQAAKRQQELKDPQLRDDLAAARAMLKKHSTMLLTASKVYVRHPELD
LAKVNRDFILKQVCDAVNTISDVAQGKSSQPTDIYSGAGELAAALDDFDEGIVMDPMTYS
EKRSRQLLEERLESIISAAALMADADCTRDERRERIVAECNAVRQALQDLLSEYMSNMSQ
KDNSPGLSRAIDQMCRKTRDLRRQLRKAVVDHVSDSFLETTTPLLDLIEAAKSGNEKKVR
EKSEIFTKHAEKLVEVANLVCSMSNNEDGVKMVRYAAAQIESLCPQVINAASILTVRPNS
KVAQENMTTYRQAWEVQVRILTEAVDDITTIDDFLAVSENHILEDVNKCVMALQVGDARD
LRATAGAIQGRSSRVCNVVEAEMDNYEPCIYTKRVLEAVKVLRDQVMMKFDQRVGAAVGA
LSNNSNKDVDENDFIDASRLVYDGVREIRRAVLMNRSSEDLDTDTEFEPVEDLTLETRSR
SSAHTGDQTVDEYPDISGICTAREAMRKMTEEDKQKIAQQVELFRREKLTFDSEVAKWDD
TGNDIIFLAKHMCMIMMEMTDFTRGRGPLKTTMDVINAAKKISEAGTKLDKLTREIAEQC
PESSTKKDLLAYLQRIALYCHQIQITSKVKADVQNISGELIVSGLDSATSLIQAAKNLMN
AVVLTVKYSYVASTKYTRQGTVSSPIVVWKMKAPEKKPLVRPEKPEEVRAKVRKGSQKKV
QNPIHALSEFQSPADAV
>sp|P00590|CUT1_FUSSO Cutinase 1 precursor (EC 3.1.1.74). 
MKFFALTTLLAATASALPTSNPAQELEARQLGRTTRDDLINGNSASCRDVIFIYARGSTE
TGNLGTLGPSIASNLESAFGKDGVWIQGVGGAYRATLGDNALPRGTSSAAIREMLGLFQQ
ANTKCPDATLIAGGYSQGAALAAASIEDLDSAIRDKIAGTVLFGYTKNLQNRGRIPNYPA
DRTKVFCNTGDLVCTGSLIVAAPHLAYGPDARGPAPEFLIEKVRAVRGSA
>sp|P18153|D7_AEDAE D7 protein precursor (Allergen Aed a 2). 
MKLLLLLAIFTTFSVVASMGPFDPEEMLFIFTRCMEDNLEDGANRLPMLAKWKEWINEPV
DSPATQCFGKCVLVRTGLYDPVAQKFDASVIQEQFKAYPSLGEKSKVEAYANAVKQLPST
NNDCAAVFKAYDPVHKAHKDTSKNLFHGNKELTKGLYEKLGKDIRQKKQSYFEFCENKYY
PAGSDKRQQLCQIRQYTVLDDALFKEHTDCVMKGIRYITKDNQLDVEEVKRDFKLVNKDT
KALEKVLNDCKSKEPSNAKEKSWHYYKCLVESSVKDDFKEAFDYREVRSQIYAFNLPKKQ
AYSKPAVQSQVMEIDGKQCPQ
>sp|P15555|DAC_STRSQ D-alanyl-D-alanine carboxypeptidase precursor (EC 3.4.16.4) (DD- 
MVSGTVGRGTALGAVLLALLAVPAQAGTAAAADLPAPDDTGLQAVLHTALSQGAPGAMVR
VDDNGTIHQLSEGVADRATGRAITTTDRFRVGSVTKSFSAVVLLQLVDEGKLDLDASVNT
YLPGLLPDDRITVRQVMSHRSGLYDYTNDMFAQTVPGFESVRNKVFSYQDLITLSLKHGV
TNAPGAAYSYSNTNFVVAGMLIEKLTGHSVATEYQNRIFTPLNLTDTFYVHPDTVIPGTH
ANGYLTPDEAGGALVDSTEQTVSWAQSAGAVISSTQDLDTFFSALMSGQLMSAAQLAQMQ
QWTTVNSTQGYGLGLRRRDLSCGISVYGHTGTVQGYYTYAFASKDGKRSVTALANTSNNV
NVLNTMARTLESAFCGKPTTAKLRSATSSATTVERHEDIAPGIARD
>sp|P24302|DERM_PHYSA Dermaseptin. 
ALWKTMLKKLGTMALHAGKAALGAAADTISQTQ
>sp|P80282|DMS1_PHYBI Dermaseptin BI precursor (Dermaseptin B1). 
MDILKKSLFLVLFLGLVSLSICEEEKRENEDEEKQDDEQSEMKRAMWKDVLKKIGTVALH
AGKAALGAVADTISQGEQ
>sp|P80280|DMS4_PHYSA Dermaseptin 4 (DS IV). 
ALWMTLLKKVLKAAAKALNAVLVGANA
>sp|Q01412|E13A_LYCES Glucan endo-1,3-beta-glucosidase A precursor (EC 3.2.1.39) 
MAFLSSLLASLLLVGLLIQITGAQPIGVCYGKIANNLPSDQDVIKLYNSNNIKKMRIYFP
ETNVFNALKGSNIEIILDVPNQDLEALANPSKRQGWVQDNIRNHFPDVKFKYIAVGNEVD
PGRDSGKYARFVGPAMENIYNALSSAGLQNQIKVSTATYLGLLTNTYPPRDSIFRDEYKS
FINPIIGFLSRHNLPLLANIYPYFGHADDNVPLPYALFKQQGLNDAGYQNLFDALVDSMY
FATEKLGGQNIEIIVSESGWPSEGHPSATLENAMTYYTNLINHVKGGAGTPKKPGRTIET
YLFAMFDENRKDGKPSEQHFGLFKPDQRPKYQLKFD
>sp|P23432|E13C_TOBAC Glucan endo-1,3-beta-glucosidase precursor (EC 3.2.1.39) ((1->3)-beta- 
MALWYLFNKRSLGAAVLILVGLLMCNIQMTGAQSNIGVCYGKIANNLPSEQDVINLYKAN
GIRKMRIYNSDTNIFKSLNGSNIEIILDVPNQDLEALANSSIANGWVQDNIRSHFPYVKF
KYISIGNEVSPSNNGQYSQFLLHAMENVYNALAAAGLQDKIKVTTATYSGLLANTYPPKD
SIFREEFKSFINPIIEFLARNNLPLLANIYPYFGHIYNTVDVPLSYALFNQQGTNSTGYQ
NLFDALLDSIYFAVEKAGGPNVEIIVSESGWPSEGNSAATIENAQTYYRNLVNHVKGGAG
TPKKPGRIVETYLFAMFDENEKNGEVTEKHFGLFYPNRTAKYQLNFMYSDT
>sp|P36401|E13H_TOBAC Glucan endo-1,3-beta-glucosidase, acidic isoform PR-Q' precursor 
MAHLIVTLLLLSVLTLATLDFTGAQAGVCYGRQGNGLPSPADVVSLCNRNNIRRMRIYDP
DQPTLEALRGSNIELMLGVPNPDLENVAASQANADTWVQNNVRNYGNVKFRYIAVGNEVS
PLNENSKYVPVLLNAMRNIQTAISGAGLGNQIKVSTAIETGLTTDTSPPSNGRFKDDVRQ
FIEPIINFLVTNRAPLLVNLYPYFAIANNADIKLEYALFTSSEVVVNDNGRGYRNLFDAI
LDATYSALEKASGSSLEIVVSESGWPSAGAGQLTSIDNARTYNNNLISHVKGGSPKRPSG
PIETYVFALFDEDQKDPEIEKHFGLFSANMQPKYQISFN
>sp|P36921|EBSB_ENTFA Cell wall enzyme EBSB. 
MLRIYVDAATKGNPGESGGGIVYLTDQSRQQLHVPLGIVSNHEAEFKVLIEALKQAIANE
DNQQTVLLHSDSKIVVQTIEKNYAKNEKYQPYLAEYQQLEKNFPLLLIKWLPESQNKAAD
MLARQALQKFYPNKK
>sp|P14756|ELAS_PSEAE Pseudolysin precursor (EC 3.4.24.26) (Elastase) (Neutral 
MKKVSTLDLLFVAIMGVSPAAFAADLIDVSKLPSKAAQGAPGPVTLQAAVGAGGADELKA
IRSTTLPNGKQVTRYEQFHNGVRVVGEAITEVKGPGKSVAAQRSGHFVANIAADLPGSTT
AAVSAEQVLAQAKSLKAQGRKTENDKVELVIRLGENNIAQLVYNVSYLIPGEGLSRPHFV
IDAKTGEVLDQWEGLAHAEAGGPGGNQKIGKYTYGSDYGPLIVNDRCEMDDGNVITVDMN
SSTDDSKTTPFRFACPTNTYKQVNGAYSPLNDAHFFGGVVFKLYRDWFGTSPLTHKLYMK
VHYGRSVENAYWDGTAMLFGDGATMFYPLVSLDVAAHEVSHGFTEQNSGLIYRGQSGGMN
EAFSDMAGEAAEFYMRGKNDFLIGYDIKKGSGALRYMDQPSRDGRSIDNASQYYNGIDVH
HSSGVYNRAFYLLANSPGWDTRKAFEVFVDANRYYWTATSNYNSGACGVIRSAQNRNYSA
ADVTRAFSTVGVTCPSAL
>sp|P35698|ELIA_PHYME Alpha-elicitin MGM-alpha. 
TTCTSTQQTAAYVTLVSILSDSSFNQCATDSGYSMLTATALPTTAQYKLMCASTACNTMI
NKIVTLNPPDCELTVPTSGLVLNVYSYANGFSATCASL
>sp|P35699|ELIB_PHYME Beta-elicitin MGM-beta. 
TACTTTQQTAAYKTLVSILSESSFNQCSKDSGYSMLTATALPTNAQYKLMCASTACKSMI
NKIVVLNPPDCDLTVPTSGLVLDVYTYANGFSTKCASL
>sp|P20724|ELYA_BACSP Alkaline elastase YaB precursor (EC 3.4.21.-). 
MNKKMGKIVAGTALIISVAFSSSIAQAAEEAKEKYLIGFKEQEVMSQFVDQIDGDEYSIS
SQAEDVEIDLLHEFDFIPVLSVELDPEDVDALELDPAIAYIEEDAEVTTMQTVPWGINRV
QAPIAQSRGFTGTGVRVAVLDTGISNHADLRIRGGASFVPGEPNISDGNGHGTQVAGTIA
ALNNSIGVLGVAPNVDLYGVKVLGASGSGSISGIAQGLQWAANNGMHIANMSLGSSAGSA
TMEQAVNQATASGVLVVAASGNSGAGNVGFPARYANAMAVGATDQNNNRATFSQYGAGLD
IVAPGVGVQSTVPGNGYASFNGTSMATPHVAGVAALVKQKNPSWSNVQIRNHLKNTATNL
GNTTQFGSGLVNAEAATR
>sp|Q00387|EP45_XENLA Estrogen-regulated protein EP45 precursor. 
MHLLVYLSLFFALALASVTEISLDNKHRHRHEQQGHHDSAKHGHQKDKQQQEQIKNDEGK
LTKEEKILSEENSDFSVNLFNQLSTESKRSPRKNIFFSPISISAAFYMLALGAKSETHQQ
ILKGLSFNKKKLSESQVHEAFKRLIEDSNNPMKAHQFTIGNALFVEQTVNILKGFEENVK
HYYQAGVFPMNFKDPDNAKKQLNNYVKDKTHGVIQEMIRELDSNTEMVLVNYVLYKGEWA
NNFNPTLTQKSLFSVDKNTNVTVQMMNRLGLYRTYQDDDCKIIELPYKNDTAMLLVFPQL
GKIQELVLTSKLINHWYESLATSIVDLYMPTFSISGKVVLKDTLRKMGISDIFTDKADLT
GISEQIKLKVSMASHNAVLNVNEFGTEAVGATSAQASPTKLFPPFLIDSPFLVMIYSRTL
GSQLFMGKVMDPTNAQ
>sp|P33709|EPO_SHEEP Erythropoietin precursor. 
MGARDCTPLLLLLLSFLLFPLGLPVLGAPPRLICDSRVLERYILEAREAENATMGCAEGC
SFSENITVPDTKVNFYAWKRMEVQQQALEVWQGLALLSEAIFRGQALLANASQPCEALRL
HVDKAVSGLRSLTSLLRALGAQKEAIPLPDATPSAAPLRIFTVDALSKLFRIYSNFLRGK
LTLYTGEACRRGDR
>sp|P40844|ES1B_RANES Esculentin-1B precursor. 
MFTLKKPLLLIVLLGMISLSLCEQERNADEEEGSEIKRGIFSKLAGKKLKNLLISGLKNV
GKEVGMDVVRTGIDIAGCKIKGEC
>sp|P40845|ES2A_RANES Esculentin-2A. 
GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC
>sp|P40846|ES2B_RANES Esculentin-2B. 
GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC
>sp|P35578|ESP4_LACVV Epididymal secretory protein IV precursor (LESP IV) (C731). 
MIAVLLLVFGMTPDYIFPVSADIPVVPNFDAQKTVGKWHPIGMASKLPEVPEYEQKISPM
DHMVELTDGDMKLTANYMDGVCKEATAMLKHTDKPGVFKFTGGEIRMMDIDYEKYLIMYM
KKSTFEAMYLSARGSDVGDDIKEKFKKLVLEQNFPEAHIKYFNAEQCTPTAA
>sp|P09582|ESTA_CANFA Arginine esterase precursor (EC 3.4.21.35). 
MWFLALCLAMSLGWTGAEPHFQPRIIGGRECLKNSQPWQVAVYHNGEFACGGVLVNPEWV
LTAAHCANSNCEVWLGRHNLSESEDEGQLVQVRKSFIHPLYKTKVPRAVIRPGEDRSHDL
MLLHLEEPAKITKAVRVMDLPKKEPPLGSTCYVSGWGSTDPETIFHPGSLQCVDLKLLSN
NQCAKVYTQKVTKFMLCAGVLEGKKDTCKGDSGGPLICDGELVGITSWGATPCGKPQMPS
LYTRVMPHLMWIKDTMKANT
>sp|P23776|EXG1_YEAST Glucan 1,3-beta-glucosidase I/II precursor (EC 3.2.1.58) (Exo-1,3- 
MLSLKTLLCTLLTVSSVLATPVPARDPSSIQFVHEENKKRYYDYDHGSLGEPIRGVNIGG
WLLLEPYITPSLFEAFRTNDDNDEGIPVDEYHFCQYLGKDLAKSRLQSHWSTFYQEQDFA
NIASQGFNLVRIPIGYWAFQTLDDDPYVSGLQESYLDQAIGWARNNSLKVWVDLHGAAGS
QNGFDNSGLRDSYKFLEDSNLAVTTNVLNYILKKYSAEEYLDTVIGIELINEPLGPVLDM
DKMKNDYLAPAYEYLRNNIKSDQVIIIHDAFQPYNYWDDFMTENDGYWGVTIDHHHYQVF
ASDQLERSIDEHIKVACEWGTGVLNESHWTVCGEFAAALTDCTKWLNSVGFGARYDGSWV
NGDQTSSYIGSCANNDDIAYWSDERKENTRRYVEAQLDAFEMRGGWIIWCYKTESSLEWD
AQRLMFNGLFPQPLTDRKYPNQCGTISN
>sp|P37889|FBL2_MOUSE Fibulin-2 precursor. 
MLLQESAGVWLALALVTALTPSPSMAVPWQDCTGAECPLLENCIEEALEPGACCATCVQQ
GCACEGYQYYDCVQGGFVDGRVPAGQSYFVDFGSTECSCPPGGGKISCQFMLCPELPPNC
IEAVVVADSCPQCGQVGCVHSGRKYAAGHTVHLSSCRACHCPDAGGELICYQLPGCHGNF
SDAEEGDSERQYEDPYSYDQEVAEAEATTAIVNEVQAGAEGPPAALGGGNLPPSSIRVTP
WPVALPRPTAAAALGPPAPVQAKARRVTLDTEEDEEEEEEETLVTEPPTAGSPGRLDSLP
TRSPARPGFPVQEKEAEAKAGPEENLIPDAQVTPRSVMQEGAAPVPRSGLAALSPSLATD
SSSEDPVKPSDHPTLSTLPPDRAQVSPSPETPEEIPQHPQLLPRFRAEEDIDPNSVHSVP
RGDLDGSTKDLIETCCAAGQQWAIDNDECQEIPENGAQSDICRIAQRQCCISYLKEKSCV
AGVMGAKEGETCGAEDNDTCGVSLYKQCCDCCGLGLRVRAEGQSCESNPNLGYPCNHVML
SCCEGEEPLIVPEVRRPPEPEAAPRRVSEMEMASREALSLGTEAELPNSLPGDDQDECLM
LPGELCQHLCINTVGSYRCACFPGFELQGDGRTCRPDRGAPQLDTARESAPRSESAQVSP
NTIPLPVPQPNTCKDNGPCRQVCRVVGDTAMCSCFPGYAIMADGVSCEDQDECLMGTHDC
SWKQFCVNTLGSFYCVNHTVLCAEGYILNAHRKCVDINECVTDLHTCTRAEHCVNTPGSF
QCYKALTCEPGYVLTDGECTDVDECVTGTHNCQAGFSCQNTKGSFYCQARQRCMDGFLQD
PEGNCVDINECTSLLEPCRSGFSCINTVGSYTCQRNPLVCGRGYHANEEGSECVDVNECE
TGVHRCGEGQLCYNLPGSYRCDCKPGFQRDAFGRTCIDVNECWVSPGRLCQHTCENTPGS
YRCSCAAGFLLAADGKHCEDVNECETRRCSQECANIYGSYQCYCRQGYQLAEDGHTCTDI
DECAQGAGILCTFRCVNVPGSYQCACPEQGYTMMANGRSCKDLDECALGTHNCSEAETCH
NIQGSFRCLRFDCPPNYVRVSQTKCERTTCQDITECQTSPARITHYQLNFQTGLLVPAHI
FRIGPAPAFAGDTISLTITKGNEEGYFVTRRLNAYTGVVSLQRSVLEPRDFALDVEMKLW
RQGSVTTFLAKMYIFFTTFAP
>sp|P23142|FBL1_HUMAN Fibulin-1 precursor. 
MERAAPSRRVPLPLLLLGGLALLAAGVDADVLLEACCADGHRMATHQKDCSLPYATESKE
CRMVQEQCCHSQLEELHCATGISLANEQDRCATPHGDNASLEATFVKRCCHCCLLGRAAQ
AQGQSCEYSLMVGYQCGQVFRACCVKSQETGDLDVGGLQETDKIIEVEEEQEDPYLNDRC
RGGGPCKQQCRDTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCRLGESCINTVGSF
RCQRDSSCGTGYELTEDNSCKDIDECESGIHNCLPDFICQNTLGSFRCRPKLQCKSGFIQ
DALGNCIDINECLSISAPCPIGHTCINTEGSYTCQKNVPNCGRGYHLNEEGTRCVDVDEC
APPAEPCGKGHRCVNSPGSFRCECKTGYYFDGISRMCVDVNECQRYPGRLCGHKCENTLG
SYLCSCSVGFRLSVDGRSCEDINECSSSPCSQECANVYGSYQCYCRRGYQLSDVDGVTCE
DIDECALPTGGHICSYRCINIPGSFQCSCPSSGYRLAPNGRNCQDIDECVTGIHNCSINE
TCFNIQGAFRCLAFECPENYRRSAATLQQEKTDTVRCIKSCRPNDVTCVFDPVHTISHTV
ISLPTFREFTRPEEIIFLRAITPPHPASQANIIFDITEGNLRDSFDIIKRYMDGMTVGVV
RQVRPIVGPFHAVLKLEMNYVVGGVVSHRNVVNVRIFVSEYWF
>sp|P35555|FBN1_HUMAN Fibrillin 1 precursor. 
MRRGRLLEIALGFTVLLASYTSHGADANLEAGNVKETRASRAKRRGGGGHDALKGPNVCG
SRYNAYCCPGWKTLPGGNQCIVPICRHSCGDGFCSRPNMCTCPSGQIAPSCGSRSIQHCN
IRCMNGGSCSDDHCLCQKGYIGTHCGQPVCESGCLNGGRCVAPNRCACTYGFTGPQCERD
YRTGPCFTVISNQMCQGQLSGIVCTKQLCCATVGRAWGHPCEMCPAQPHPCRRGFIPNIR
TGACQDVDECQAIPGLCQGGNCINTVGSFECKCPAGHKLNEVSQKCEDIDECSTIPGICE
GGECTNTVSSYFCKCPPGFYTSPDGTRCIDVRPGYCYTALTNGRCSNQLPQSITKMQCCC
DAGRCWSPGVTVAPEMCPIRATEDFNKLCSVPMVIPGRPEYPPPPLGPIPPVLPVPPGFP
PGPQIPVPRPPVEYLYPSREPPRVLPVNVTDYCQLVRYLCQNGRCIPTPGSYRCECNKGF
QLDLRGECIDVDECEKNPCAGGECINNQGSYTCQCRAGYQSTLTRTECRDIDECLQNGRI
CNNGRCINTDGSFHCVCNAGFHVTRDGKNCEDMDECSIRNMCLNGMCINEDGSFKCICKP
GFQLASDGRYCKDINECETPGICMNGRCVNTDGSYRCECFPGLAVGLDGRVCVDTHMRST
CYGGYKRGQCIKPLFGAVTKSECCCASTEYAFGEPCQPCPAQNSAEYQALCSSGPGMTSA
GSDINECALDPDICPNGICENLRGTYKCICNSGYEVDSTGKNCVDINECVLNSLLCDNGQ
CRNTPGSFVCTCPKGFIYKPDLKTCEDIDECESSPCINGVCKNSPGSFICECSSESTLDP
TKTICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLGAAWGSPCTLCQVDPICGKGY
SRIKGTQCEDIDECEVFPGVCKNGLCVNTRGSFKCQCPSGMTLDATGRICLDIRLETCFL
RYEDEECTLPIAGRHRMDACCCSVGAAWGTEECEECPMRNTPEYEELCPRGPGFATKEIT
NGKPFFKDINECKMIPSLCTHGKCRNTIGSFKCRCDSGFALDSEERNCTDIDECRISPDL
CGRGQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGGVCHNTEGSYRCEC
PPGHQLSPNISACIDINECELSAHLCPNGRCVNLIGKYQCACNPGYHSTPDRLFCVDIDE
CSIMNGGCETFCTNSEGSYECSCQPGFALMPDQRSCTDIDECEDNPNICDGGQCTNIPGE
YRCLCYDGFMASEDMKTCVDVNECDLNPNICLSGTCENTKGSFICHCDMGYSGKKGKTGC
TDINECEIGAHNCGKHAVCTNTAGSFKCSCSPGWIGDGIKCTDLDECSNGTHMCSQHADC
KNTMGSYRCLCKEGYTGDGFTCTDLDECSENLNLCGNGQCLNAPGGYRCECDMGFVPSAD
GKACEDIDECSLPNICVFGTCHNLPGLFRCECEIGYELDRSGGNCTDVNECLDPTTCISG
NCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVSKA
SCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGG
KCINTFGSFQCRCPTGYYLNEDTRVCDDVNECETPGICGPGTCYNTVGNYTCICPPDYMQ
VNGGNNCMDMRRSLCYRNYYADNQTCDGELLFNMTKKMCCCSYNIGRAWNKPCEQCPIPS
TDEFATLCGSQRPGFVIDIYTGLPVDIDECREIPGVCENGVCINMVGSFRCECPVGFFYN
DKLLVCEDIDECQNGPVCQRNAECINTAGSYRCDCKPGYRFTSTGQCNDRNECQEIPNIC
SHGQCIDTVGSFYCLCHTGFKTNDDQTMCLDINECERDACGNGTCRNTIGSFNCRCNHGF
ILSHNNDCIDVDECASGNGNLCRNGQCINTVGSFQCQCNEGYEVAPDGRTCVDINECLLE
PRKCAPGTCQNLDGSYRCICPPGYSLQNEKCEDIDECVEEPEICALGTCSNTEGSFKCLC
PEGFSLSSSGRRCQDLRMSYCYAKFEGGKCSSPKSRNHSKQECCCALKGEGWGDPCELCP
TEPDEAFRQICPYGSGIIVGPDDSAVDMDECKEPDVCKHGQCINTDGSYRCECPFGYTLA
GNECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEPGPMMTCEDINECAQNPLLCAFR
CVNTYGSYECKCPVGYVLREDRRMCKDEDECEEGKHDCTEKQMECKNLIGTYMCICGPGY
QRRPDGEGCVDENECQTKPGICENGRCLNTRGSYTCECNDGFTASPNQDECLDNREGYCF
TEVLQNMCQIGSSNRNPVTKSECCCDGGRGWGPHCEICPFQGTVAFKKLCPHGRGFMTNG
ADIDECKVIHDVCRNGECVNDRGSYHCICKTGYTPDITGTSCVDLNECNQAPKPCNFICK
NTEGSYQCSCPKGYILQEDGRSCKDLDECATKQHNCQFLCVNTIGGFTCKCPPGFTQHHT
SCIDNNECTSDINLCGSKGICQNTPGSFTCECQRGFSLDQTGSSCEDVDECEGNHRCQHG
CQNIIGGYRCSCPQGYLQHYQWNQCVDENECLSAHICGGASCHNTLGSYKCMCPAGFQYE
QFSGGCQDINECGSAQAPCSYGCSNTEGGYLCGCPPGYFRIGQGHCVSGMGMGRGNPEPP
VSGEMDDNSLSPEACYECKINGYPKRGRKRRSTNETDASNIEDQSETEANVSLASWDVEK
TAIFAFNISHVSNKVRILELLPALTTLTNHNRYLIESGNEDGFFKINQKEGISYLHFTKK
KPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH
>sp|P21781|FGF7_HUMAN Keratinocyte growth factor precursor (KGF) (Fibroblast growth factor- 
MHKWILTWILPTLLYRSCFHIICLVGTISLACNDMTPEQMATNVNCSSPERHTRSYDYME
GGDIRVRRLFCRTQWYLRIDKRGKVKGTQEMKNNYNIMEIRTVAVGIVAIKGVESEFYLA
MNKEGKLYAKKECNEDCNFKELILENHYNTYASAKWTHNGGEMFVALNQKGIPVRGKKTK
KEQKTAHFLPMAIT
>sp|P37924|FIMD_SALTY Outer membrane usher protein fimD precursor. 
MKKTTWFAGRFPGYVSPLSSVALSVLAALCPLTSRGESYFNPAFLSADTASVADLSRFEK
GNHQPPGIYRVDIWRNDEFVATQDIRFEAGAVGTGDKSGGLMPCFTPEWIKRLGVNTAAF
PVSDKGVDTTCIHLPEKIPGAEVAFDFASMRLNISLPQASLLNSARGYIPPEEWDEGIPA
ALINYSFTGSRGTDSDSYFLSLLSGLNYGPWRLRNNGAWNYSKGDGYHSQRWNNIGTWVQ
RAIIPLKSELVMGDSNTGNDVFDSVGFRGARLYSSDNMYPDSLQGYAPTVRGIARTAAKL
TIRQNGYVIYQSYVSPGAFAITDLNPTSSSGDLEVTVDEKDGSQQRYTVPYSTVPLLQRE
GRVKYDLVAGDFRSGNSQQSSPFFFQGTVIAGLPAGLTAYGGTQLADRYRAVVVGAGRNL
GDWGAVSVDVTHARSQLADDSTHQGQSLRFLYAKSLNNYGTNFQLLGYRYSTRGFYTLDD
VAYRSMEGYDYEYDSDGRRHKVPVAQSYHNLRYSKKGRFQVNISQNLGDYGSLYLSGSQQ
NYWNTADTNTWYQLGYASGWQGISYSLSWSWSESVGSSGADRILAFNMSVPFSVLTGRRY
ARDTILDRTYATFNANRNRDGDNSWQTGVGGTLLEGRNLSYSVTQGRSSSNGYSGSASAS
WQATYGTLGVGYNYDRDQHDYNWQLSGGVVGHADGITFSQPLGDTNVLIKAPGAKGVRIE
NQTGVKTDWRGYAVMPYATVYRYNRVALDTNTMDNHTDVENNVSSVVPTEGALVRAAFDT
RIGVRAIITARLGGRPLPFGAIVRETASGITSMVGDDGQIYLSGLPLKGELFIQWGEGKN
ARCIAPYALAEDSLKQAITIASATCIRPAS
>sp|P02751|FINC_HUMAN Fibronectin precursor (FN) (Cold-insoluble globulin) (CIG). 
MLRGPGPGLLLLAVQCLGTAVPSTGASKSKRQAQQMVQPQSPVAVSQSKPGCYDNGKHYQ
INQQWERTYLGNALVCTCYGGSRGFNCESKPEAEETCFDKYTGNTYRVGDTYERPKDSMI
WDCTCIGAGRGRISCTIANRCHEGGQSYKIGDTWRRPHETGGYMLECVCLGNGKGEWTCK
PIAEKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSY
RIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTSVQTTSSGSGPFTDVRAAVYQPQPHP
QPPPYGHCVTDSGVVYSVGMQWLKTQGNKQMLCTCLGNGVSCQETAVTQTYGGNSNGEPC
VLPFTYNGRTFYSCTTEGRQDGHLWCSTTSNYEQDQKYSFCTDHTVLVQTQGGNSNGALC
HFPFLYNNHNYTDCTSEGRRDNMKWCGTTQNYDADQKFGFCPMAAHEEICTTNEGVMYRI
GDQWDKQHDMGHMMRCTCVGNGRGEWTCIAYSQLRDQCIVDDITYNVNDTFHKRHEEGHM
LNCTCFGQGRGRWKCDPVDQCQDSETGTFYQIGDSWEKYVHGVRYQCYCYGRGIGEWHCQ
PLQTYPSSSGPVEVFITETPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIP
GHLNSYTIKGLKPGVVYEGQLISIQQYGHQEVTRFDFTTTSTSTPVTSNTVTGETTPFSP
LVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDL
LPGRKYIVNVYQISEDGEQSLILSTSQTTAPDAPPDPTVDQVDDTSIVVRWSRPQAPITG
YRIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVVIQQETTG
TPRSDTVPSPRDLQFVEVTDVKVTIMWTPPESAVTGYRVDVIPVNLPGEHGQRLPISRNT
FAEVTGLSPGVTYYFKVFAVSHGRESKPLTAQQTTKLDAPTNLQFVNETDSTVLVRWTPP
RAQITGYRLTVGLTRRGQPRQYNVGPSVSKYPLRNLQPASEYTVSLVAIKGNQESPKATG
VFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVV
SGLTPGVEYVYTIQVLRDGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWERSTT
PDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPIS
DTIIPAVPPPTDLRFTNIGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSD
NAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGRQKTGLDSPTGIDFSDITANSFTVHWIA
PRATITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSIVALNGREESPLL
IGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVRYYRITYGETGGNSPVQEFTVPGSK
STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYRTEIDKPSQMQVTDVQDNSISV
KWLPSSSPVTGYRVTTTPKNGPGPTKTKTAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGE
SQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQVSRYRVTYSSPEDGIHELFPAP
DGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLIGTQSTAIPAPTDLKFTQVTPTSLSA
QWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLT
SRPAQGVVTTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAVPANGQTPIQRT
IKPDVRSYTITGLQPGTDYKIYLYTLNDNARSSPVVIDASTAIDAPSNLRFLATTPNSLL
VSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQ
KSEPLIGRKKTDELPQLVTLPHPNLHGPEILDVPSTVQKTPFVTHPGYDTGNGIQLPGTS
GQQPSVGQQMIFEEHGFRRTTPPTTATPIRHRPRPYPPNVGEEIQIGHIPREDVDYHLYP
HGPGLNPNASTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFRVPGTSTSATLT
GLTRGATYNIIVEALKDQQRHKVREEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDE
WERMSESGFKLLCQCLGFGSGHFRCDSSRWCHDNGVNYKIGEKWDRQGENGQMMSCTCLG
NGKGEFKCDPHEATCYDDGKTYHVGEQWQKEYLGAICSCTCFGGQRGWRCDNCRRPGGEP
SPEGTTGQSYNQYSQRYHQRTNTNVNCPIECFMPLDVQADREDSRE
>sp|P40795|FOG_DROME Folded gastrulation protein precursor. 
MSPPNCLLAVLALTVFIGANNALPITSRPIEGNVQRMVWEDWVNLDPEQRNLTKEKKITA
KSIFTLPFRHCPQGHTLFNQLCIPQSNIDPTDLVKQELILAGGSNGSPPPPPIGDYDYGD
DEESEEIVYDLSVIPTAMQDGLPPSVGTGDQALPSEDAPLKFNIFEKKFPTGTGEHEEMP
LPPDMAAATYAKNISTTPETSTSITPTSTTTFAVPSVPSGEASNRIPGGVDLLAAPSDAF
STSTTLSMPTSNTTTTSNKDIGQVESIVLPADQEHDGLVHLVTSSLSDNDSDDSSTTLNG
FNAEADLAQLLKVDAFWPVYDGSIELLPPLFSHRKVAPPLSADQDVKTKHAVDAAEKVGA
ELEEEVGEEEVTATDILPSEEDEYTTETATTTGDTTVAEASMDTSTATSTSGQSSPHPPE
EPEIDERENRLVLIKSKVQPVQLTTTTSATATTAADVANSSSSTDRFHYQHFVEDESSTT
TATPEPSSSTPGDPIEQSDMPASDNDNLMTNTIGGRGDDDDDGGHKATSEIHVQQELRLI
NELVKGKQRQQHQPQKQQLEPTSTEITSALTSTSTEDATTTTTTTTAYTNWSKVMPQLGQ
STSETAATTETVATSGQVNEISLTATSASTEVKHFSITNRSYRNSKIIREDRLTVEPEGI
VESAASTESAGTAATTPNSSSNPDGYTPLWWLPSIGWRLDRHLDGNGEDQSLLLRFFSTF
RGSNTAATTR
>sp|P35446|FSPO_RAT F-spondin precursor. 
MRLSPAPLRLSRGPALLALALPLAAALAFSDETLDKVAKSEGYCSRILRAQGTRREGYTE
FSLRVEGDPDFYKPGSSYRVTLSAAPPSYFRGFTLIALKENREGDKEEDHAGTFQIIDEE
ETQFMSNCPVAVTESTPRRRTRIQVFWIAPPTGTGCVILKASIVQKRIIYFQDEGSLTKK
LCEQDPTLDGVTDRPILDCCACGTAKYRLTFYGNWSEKTHPKDYPRRANHWSAIIGGSHS
KNYVLWEYGGYASEGVKQVAELGSPVKMEEEIRQQSDEVLTVIKAKAQWPSWQPVNVRAA
PSAEFSVDRTRHLMSFLTMMGPSPDWNVGLSAEDLCTKECGWVQKVVQDLIPWDAGTDSG
VTYESPNKPTIPQEKIRPLTSLDHPQSPFYDPEGGSITQVARVVIERIARKGEQCNIVPD
NVDDIVADLAPEEKDEDDTPETCIYSNWSPWSACSSSTCEKGKRMRQRMLKAQLDLSVPC
PDTQDFQPCMGPGCSDEDGSTCTMSEWITWSPCSVSCGMGMRSRERYVKQFPEDGSVCML
PTEETEKCTVNEECSPSSCLVTEWGEWDDCSATCGMGMKKRHRMVKMSPADGSMCKAETS
QAEKCMMPECHTIPCLLSPWSEWSDCSVTCGKGMRTRQRMLKSLAELGDCNEDLEQAEKC
MLPECPIDCELSEWSQWSECNKSCGKGHMIRTRTIQMEPQFGGAPCPETVQRKKCRARKC
LRSPSIQKLRWREARESRRSEQLREESDGEQFPGCRMRPWTAWSECTKLCGGGIQERYMT
VKKRFKSSQFTSCKDKKEIRACNVHPC
>sp|P34116|G13B_DICDI Cell surface glycoprotein GP138B precursor. 
MKIILTLSIFLICFLQLGQSVIDPSQNEVMSDLLFNLYGYDKSLDPCNSNSVECDDINST
STIKTVISLNLPTPLQEYVITQDLTPLQNLTYMELYEKIYLTLSFFKNINKLTQLETIVT
LSFNVTIPDDTIFPASLETFSIYKPSVPLSIAIFGSNIKNLYVNSPLTGYSIPTLINVNP
YLENLQLPVTYYSGFPSNISLAFPNLQYLTIYVNNDMDQNNYHNFSISNIGVFKNLKGLD
IEFTDSYNPQEFSINSFLSNVPVIDSLYIYGQGVTIDPSVGIIDLSYVKSKKFLSINIQE
SSLLNNCKGKSFKSPKKAYFRSNYNTFSYACIDFSNLAYFYDYYNEYEQYLPNIDNAPLL
NEIYISESVVVGDIPESYCRINYLGLNYNQLNGTAPSCILCLGGNRGGDIVLPNPLLNFN
KTSEPYCPTFKIDQNYTNLVATDGIGKLIITGTNLGWYGNDITPITANSKLAITIPKGVG
TNKSITVTFQNGEQRTFNYSYVPPFIKSYGFLELDSNKYLTINGTGFDFENPNIITINGQ
QITFSIALGGGDNDGLIALPIDELPNFDSETKFTVSTLVGGQSSNEVTFYYFNSINITEE
KLVLNNTGGSVDINGSFGTNNISLVSISINGTNCLVTSYTNSKLTIQYPSKQVGDNYVLT
LNVGGYAVNLVVEYIEGGETPTPSTTPSTTPSTTPSTTPSSTPTQSPGDDGSTSSTLSIS
FYLITLLLLTQQFI
>sp|Q01745|GAOA_DACDE Galactose oxidase precursor (EC 1.1.3.9) (GAO). 
MKHLLTLALCFSSINAVAVTVPHKAVGTGIPEGSLQFLSLRASAPIGSAISRNNWAVTCD
SAQSGNECNKAIDGNKDTFWHTFYGANGDPKPPHTYTIDMKTTQNVNGLSMLPRQDGNQN
GWIGRHEVYLSSDGTNWGSPVASGSWFADSTTKYSNFETRPARYVRLVAITEANGQPWTS
IAEINVFQASSYTAPQPGLGRWGPTIDLPIVPAAAAIEPTSGRVLMWSSYRNDAFGGSPG
GITLTSSWDPSTGIVSDRTVTVTKHDMFCPGISMDGNGQIVVTGGNDAKKTSLYDSSSDS
WIPGPDMQVARGYQSSATMSDGRVFTIGGSWSGGVFEKNGEVYSPSSKTWTSLPNAKVNP
MLTADKQGLYRSDNHAWLFGWKKGSVFQAGPSTAMNWYYTSGSGDVKSAGKRQSNRGVAP
DAMCGNAVMYDAVKGKILTFGGSPDYQDSDATTNAHIITLGEPGTSPNTVFASNGLYFAR
TFHTSVVLPDGSTFITGGQRRGIPFEDSTPVFTPEIYVPEQDTFYKQNPNSIVRVYHSIS
LLLPDGRVFNGGGGLCGDCTTNHFDAQIFTPNYLYNSNGNLATRPKITRTSTQSVKVGGR
ITISTDSSISKASLIRYGTATHTVNTDQRRIPLTLTNNGGNSYSFQVPSDSGVALPGYWM
LFVMNSAGVPSVASTIRVTQ
>sp|P33714|GAST_MACMU Gastrin. 
QGPWMEEEEAAYGWMDF
>sp|P80221|SZ06_BOVIN Small inducible cytokine B6 precursor (CXCL6) (Granulocyte chemotactic 
MRLLSSRAARVSGPSGSLCALLALLLLTPPGPLASAGPVAAVVRELRCVCLTTTPGIHPK
TVSDLQVIAAGPQCSKVEVIATLKNGREVCLDPEAPLIKKIVQKILDSGKNN
>sp|P06396|GELS_HUMAN Gelsolin precursor, plasma (Actin-depolymerizing factor) (ADF) 
MAPHRPAPALLCALSLALCALSLPVRAATASRGASQAGAPQGRVPEARPNSMVVEHPEFL
KAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNEC
SQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVV
PNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKA
TQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKL
YKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALK
TASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERV
PFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNY
RHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFG
GKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPS
AAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDK
KMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEK
TEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAEL
AA
>sp|P15290|GER2_WHEAT Oxalate oxidase GF-2.8 precursor (EC 1.2.3.4) (Germin GF-2.8). 
MGYSKTLVAGLFAMLLLAPAVLATDPDPLQDFCVADLDGKAVSVNGHTCKPMSEAGDDFL
FSSKLAKAGNTSTPNGSAVTELDVAEWPGTNTLGVSMNRVDFAPGGTNPPHIHPRATEIG
IVMKGELLVGILGSLDSGNKLYSRVVRAGETFLIPRGLMHFQFNVGKTEASMVVSFNSQN
PGIVFVPLTLFGSNPPIPTPVLTKALRVEARVVELLKSKFAAGF
>sp|P27613|GLBH_TRICO Globin-like host-protective antigen precursor. 
MRFLLLAAFVAYAYAKSDEEIRKDALSALDVVPLGSTPEKLENGREFYKYFFTNHQDLRK
YFKGAETFTADDIAKSDRFKKLGNQLLLSVHLAADTYDNEMIFRAFVRDTIDRHVDRGLD
PKLWKEFWSIYQKFLESKGKTLSADQKAAFDAIGTRFNDEAQKQLAHHGLPHT
>sp|P31178|GLE_CHLRE Autolysin precursor (EC 3.4.24.38) (Gametolysin) (Gamete lytic enzyme) 
MSLATRRFGAAAALLVAACVLCTAPAWAQNETTGTGMVKTKSAFRWIRPPPARPPPFRRP
PPAQTPYVHKVEYTELQILCPQTIDSVTGYPMDDPRCNVPRATVAAGEEALTIRNEFELL
NGDVLNVTLEEVDTPENPSRRRLLSIIREEQRTGRVLLATSAELPTPTFRLKSLKSILKG
SQKEIYAGKPIDLRTIVYIMDFSSCKLSGWSAPATLTPEKVTSDMLRGASAPTNNLANYY
GACSYEKTLFNPDNFLVLGPVPVPCIGGVTPPPRPPRPPRPPPRAGSTISSLSRRNDTYD
DWWDLSKYCTASEQQAWERAAEAYAQAIVAQDPNSATGKKLQGILQWRERRRNIYILPPG
VKCSWSGYADVTCTSATCSAYVRGYSDTNAMQVIMHEAMHNYGLEHAGRGTLEYGDATDV
MGDFNKAGKGLLCPNAPNMYRIGWAKPINEPGVAPFQNATGAWGNLTAANFTTDPWIRGL
VIPAQGTRDDNMIVVNVGAQSTRDGAMKATGAQAYYFSYRIKNTTAGGYDSGLTLDFHKK
VLVHAYNGIQSERVFGFKSNLLDWGPNFQSRSNTWTSPFLAYNNGLGGGVRLVVQSTSDT
QAVVDICRISENGKELSCDDGIDNDCDGLQDNEDPDCQ
>sp|P12850|GRO_MOUSE Growth regulated protein precursor (CXCL1) (Platelet-derived growth 
MIPATRSLLCAALLLLATSRLATGAPIANELRCQCLQTMAGIHLKNIQSLKVLPSGPHCT
QTEVIATLKNGREACLDPEAPLVQKIVQKMLKGVPK
>sp|P23764|GSHP_RAT Plasma glutathione peroxidase precursor (EC 1.11.1.9) (GSHPx-P). 
MSRILRASCLLSLLLAGFVPPGRGQEKSKTDCHGGMSGTIYEYGALTIDGEEYIPFKQYA
GKYILFVNVASYCGLTDQYLELNALQEELGPFGLVILGFPCNQFGKQEPGENSEILPSLK
YVRPGGGFVPNFQLFEKGDVNGEKEQKFYTFLKNSCPPTAELLGSPGRLFWEPMKIHDIR
WNFEKFLVGPDGIPIMRWYHRTTVSNVKMDILSYMRRQAALGARGK
>sp|P11001|GTF1_STRDO Glucosyltransferase-I precursor (EC 2.4.1.5) (GTF-I) (Dextransucrase) 
MEKNERFKMHKVKKRWVTISVASATMLASALGASVASADTETVSEDSNQAVLTADQTTTN
QDTEQTSVAATATSEQSASTDAATDQASATDQASAAEQTQGTTASTDTAAQTTTNANEAK
WVPTENENQVFTDEMLAEAKNVATAESNSIPSDLAKMSNVKQVDGKYYYYDQDGNVKKNF
AVSVGEKIYYFDETGAYKDTSKVEADKSGSDISKEETTFAANNRAYSTSAENFEAIDNYL
TADSWYRPKSILKDGKTWTESSKDDFRPLLMAWWPDTETKRNYVNYMNKVVGIDKTYTAE
TSQADLTAAAELVQARIEQKITTEQNTKWLREAISAFVKTQPQWNGESEKPYDDHLQNGA
LKFDNQSDLTPDTQSNYRLLNRTPTNQTGSLDSRFTYNANDPLGGYELLLANDVDNSNPI
VQAEQLNWLHYLLNFGTIYAKDADANFDSIRVDAVDNVDADLLQISSDYLKAAYGIDKNN
KNANNHVSIVEAWSDNDTPYLHDDGDNLMNMDNKFRLSMLWSLAKPLDKRSGLNPLIHNS
LVDREVDDREVETVPSYSFARAHDSEVQDLIRDIIKAEINPNAFGYSFTQDEIDQAFKIY
NEDLKKTDKKYTHYNVPLSYTLLLTNKGSIPRVYYGDMFTDDGQYMANKTVNYDAIESLL
KARMKYVAGGQAMQNYQIGNGEILTSVRYGKGALKQSDKGDATTRTSGVGVVMGNQPNFS
LDGKVVALNMGAAHANQEYRALMVSTKDGVATYATDADASKAGLVKRTDENGYLYFLNDD
LKGVANPQVSGFLQVWVPVGAADDQDIRVAASDTASTDGKSLHQDAAMDSRVMFEGFSNF
QSFATKEEEYTNVVIANNVDKFVSWGITDFEMAPQYVSSTDGQFLDSVIQNGYAFTDRYD
LGMSKANKYGTADQLVKAIKALHAKGLKVMADWVPDQMYTFPKQEVVTVTRTDKFGKPIA
GSQINHSLYVTDTKSSGDDYQAKYGGAFLDELKEKYPELFTKKQISTGQAIDPSVKIKQW
SAKYFNGSNILGRGADYVLSDQASNKYLNVSDDKLFLPKTLLGQVVESGIRFDGTGYVYN
SSTTGEKVTDSFITEAGNLYYFGQDGYMVTGAQNIKGSNYYFLANGAALRNTVYTDAQGQ
NHYYGNDGKRYENGYQQFGNDSWRYFKNGVMALGLTTVDGHVQYFDKDGVQAKDKIIVTR
DGKVRYFDQHNGNAVTNTFVADKTGHWYYLGKDGVAVTGAQTVGKQHLYFEANGQQVKGD
FVTAKDGKLYFYDVDSGDMWTNTFIEDKAGNWFYLGKDGAAVTGAQTIKGQKLYFKANGQ
QVKGDIVKDADGKIRYYDAQTGEQVFNKSVSVNGKTYYFGSDGTAQTQANPKGQTFKDGS
GVLRFYNLEGQYVSGSGWYETAEHEWVYVKSGKVLTGAQTIGNQRVYFKDNGHQVKGQLV
TGNDGKLRYYDANSGDQAFNKSVTVNGKTYYFGSDGTAQTQANPKGQTFKDGSGVLRFYN
LEGQYVSGSGWYKNAQGQWLYVKDGKVLTGLQTVGNQKVYFDKNGIQAKGKAVRTSDGKV
RYFDENSGSMITNQWKFVYGQYYYFGSDGAAVYRGWN
>sp|P04957|GUB_BACSU Beta-glucanase precursor (EC 3.2.1.73) (Endo-beta-1,3-1,4 glucanase) 
MPYLKRVLLLLVTGLFMSLFAVTATASAQTGGSFFDPFNGYNSGFWQKADGYSNGNMFNC
TWRANNVSMTSLGEMRLALTSPAYNKFDCGENRSVQTYGYGLYEVRMKPAKNTGIVSSFF
TYTGPTDGTPWDEIDIEFLGKDTTKVQFNYYTNGAGNHEKIVDLGFDAANAYHTYAFDWQ
PNSIKWYVDGQLKHTATNQIPTTPGKIMMNLWNGTGVDEWLGSYNGVNPLYAHYDWVRYT
KK
>sp|P07983|GUN1_BACSU Endoglucanase precursor (EC 3.2.1.4) (Endo-1,4-beta-glucanase) 
MKRSISIFITCLLIAVLTMGGLLPSPASAAGTKTPVAKNGQLSIKGTQLVNRDGKAVQLK
GISSHGLQWYGDFVNKDSLKWLRDDWGITVFRAAMYTADGGYIDNPSVKNKVKEAVEAAK
ELGIYVIIDWHILNDGNPNQNKEKAKEFFKEMSSLYGNTPNVIYEIANEPNGDVNWKRDI
KPYAEEVISVIRKNDPDNIIIVGTGTWSQDVNDAADDQLKDANVMYALHFYAGTHGQSLR
DKANYALSKGAPIFVTEWGTSDASGNGGVFLDQSREWLNYLDSKNISWVNWNLSDKQESS
SALKPGASKTGGWPLTDLTASGTFVRENIRGTKDSTKDVPETPAQDNPTQEKGVSVQYKA
GDGRVNSNQIRPQLHIKNNGNATVDLKDVTARYWYNVKNKGQNFDCDYAQMGCGNLTHKF
VTLHKPKQGADTYLELGFKTGTLSPGASTGNIQLRLHNDDWSNYAQSGDYSFFQSNTFKT
TKKITLYHQGKLIWGTEPN
>sp|P37696|GUNA_ACEXY Probable endoglucanase precursor (EC 3.2.1.4) (Endo-1,4-beta- 
MSVMAAMGGAQVLSSTGAFADPAPDAVAQQWAIFRAKYLRPSGRVVDTGNGGESHSEGQG
YGMLFAASAGDLASFQSMWMWARTNLQHTNDKLFSWRFLKGHQPPVPDKNNATDGDLLIA
LALGRAGKRFQRPDYIQDAMAIYGDVLNLMTMKAGPYVVLMPGAVGFTKKDSVILNLSYY
VMPSLLQAFDLTADPRWRQVMEDGIRLVSAGRFGQWRLPPDWLAVNRATGALSIASGWPP
RFSYDAIRVPLYFYWAHMLAPNVLADFTRFWNNFGANALPGWVDLTTGARSPYNAPPGYL
AVAECTGLDSAGELPTLDHAPDYYSAALTLLVYIARAEETIK
>sp|Q01528|HAAF_LIMPO Hemagglutinin/amebocyte aggregation factor precursor (18K-LAF). 
MNSPAIVIIIFSTLTFSEAWVNDWDGALNFQCQLKDSIKTISSIHSNHHEDRRWNFGCER
TLRDPSCYFTNYVNDWDKLLHFTCKSGEAIAGFNSYHDNRREDRRWKIYCCKDKNKCTDY
RTCAWTGYVNSWDGDLHYTVPKDYVLTGVISEHDNHREDRRWKFQHCRLKNC
>sp|P80096|HCYC_PANIN Hemocyanin C chain. 
ADCQAGDSADKLLAQKQHDVNYLVYKLYGDIRDDHLKELGETFNPQGDLLLYHDNGASVN
TLMADFKDGRLLQKKHWFSLFNTRQREEALMMHRVLMNCKNWHAFVSNAAYFRTNMNEGE
YLYALYVSLIHSGLGEGVVLPPLYEVTPHMFTNSEVIHEAYKAQMTNTPSKFESHFTGSK
KNPEQHVAYFGEDVGMNTHHVLWHMEFPFWWEDSSGRHLDRKGESFFWVHHQLTVRYDAE
RLSNHLDPVEELSWNKAIDEGFAPHTAYKYGGYFPSRPDNVHFSDVDGVARVRDMSMTED
RIRDAIAHGYIDALDGSHIDIMNSHGIEFLGDIIESSGYSANPGFYGSLHNTAHIMLGRQ
GDPTGKFDLPPGVLEHFETSTRDPSFFRLHKYMDNIFREHKDSLTPYTRDELEFNGVSID
SIAIEGTLETFFENFEYSLLNAVDDTVDIADVEILTYIERLNHKKFSFLILVTNNNNTEV
LATVRIFAWPLRDNNGIEYSFNEGRWRALELDRFWVKVKHGHHQITRQSTESSVTVPDVP
SLQTLIDRADAAISSGCALHLEDYESALGLPNRFLLPKGQAQGMEFNLVVAVTDGRTDAA
LDDLHENTKFIHYGYDRQYPDKRPHGYPLDRRVDDERIFEALPNFKQRTVKLYSHEGVDG
G
>sp|Q99289|HLT_VIBPA Thermolabile hemolysin precursor (TL) (Lecithin-dependent haemolysin) 
MMKKTITLLTALLPLASAVAEEPTLSPEMVSASEVISTQENQTYTYVRCWYRTSYSKDDP
ATDWEWAKNEDGSYFTIDGYWWSSVSFKNMFYTNTSQNVIRQRCEATLDLANENADITFF
AADNRFSYNHTIWSNDAAMQPDQINKVVALGDSLSDTGNIFNASQWRFPNPNSWFLGHFS
NGFVWTEYIAKAKNLPLYNWAVGGAAGENQYIALTGVGDQVSSYLTYAKLAKNYKPANTL
FTLEFGLNDFMNYNRGVPEVKADYAEALIRLTDAGAKNFMLMTLPDATKAPQFKYSTQEE
IDKIRAKVLEMNEFIKAQAMYYKAQGYNITLFDTHALFETLTSAPEEHGFVNASDPCLDI
NRSSSVDYMYTHALRSECAASGAEKFVFWNVTHPTTATHRYVAEKMLESSNNLAEYRF
>sp|P28029|HLY3_VIBPA Thermostable direct hemolysin-related precursor. 
MKYRYFAKKSFLFISMLAAFKTFAFELPSVPFPAPGSDEILFVVRDATFNTNAPVNVKVS
DFWTNRNVKRKPYKDVYGQSVFTTSGTKWLTSYMTVNINDKDYTMAAVSGYKRGHSAVFV
KSDQVQLQHSYNSVANFVGEDEDSIPSKMYLDETPEYFVNVEAYESGSGNILVMCISNKE
SFFECEHQK
>sp|P06866|HPT_RAT Haptoglobin precursor. 
MRALGAVVTLLLWGQLFAVELGNDATDIEDDSCPKPPEIANGYVEHLVRYRCRQFYKLQT
EGDGIYTLNSEKQWVNPAAGDKLPKCEAVCGKPKHPVDQVQRIIGGSMDAKGSFPWQAKM
ISRHGLTTGATLISDQWLLTTAQNLFLNHSENATAKDIAPTLTLYVGKNQLVEIEKVVLH
PERSVVDIGLIKLKQKVLVTEKVMPICLPSKDYVAPGRMGYVSGWGRNVNFRFTERLKYV
MLPVADQEKCELHYEKSTVPEKKGAVTPVGVQPILNKHTFCAGLTKYEEDTCYGDAGSAF
AVHDTEEDTWYAAGILSFDKSCAVAEYGVYVKATDLKDWVQETMAKN
>sp|P00738|HPT2_HUMAN Haptoglobin-2 precursor. 
MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT
EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE
GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV
SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP
NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM
LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA
VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN
>sp|Q01099|HRPN_ERWAM Harpin (Harpin-EA). 
MSLNTSGLGASTMQISIGGAGGNNGLLGTSRQNAGLGGNSALGLGGGNQNDTVNQLAGLL
TGMMMMMSMMGGGGLMGGGLGGGLGNGLGGSGGLGEGLSNALNDMLGGSLNTLGSKGGNN
TTSTTNSPLDQALGINSTSQNDDSTSGTDSTSDSSDPMQQLLKMFSEIMQSLFGDGQDGT
QGSSSGGKQPTEGEQNAYKKGVTDALSGLMGNGLSQLLGNGGLGGGQGGNAGTGLDGSSL
GGKGLQNLSGPVDYQQLGNAVGTGIGMKAGIQALNDIGTHSDSSTRSFVNKGDRAMAKEI
GQFMDQYPEVFGKPQYQKGPGQEVKTDDKSWAKALSKPDDDGMTPASMEQFNKAKGMIKS
AMAGDTGNGNLQARGAGGSSLGIDAMMAGDAINNMALGKLGAA
>sp|P33129|HTRE_ECOLI Outer membrane usher protein htrE precursor (Heat shock protein E). 
MTIEYTKNYHHLTRIATFCALLYCNTAFSAELVEYDHTFLMGQNASNIDLSRYSEGNPAI
PGVYDVSVYVNDQPIINQSITFVAIEGKKNAQACITLKNLLQFHINSPDINNEKAVLLAR
DETLGNCLNLTEIIPQASVRYDVNDQRLDIDVPQAWVMKNYQNYVDPSLWENGINAAMLS
YNLNGYHSETPGRKNESIYAAFNGGMNLGAWRLRASGNYNWMTDSGSNYDFKNRYVQRDI
ASLRSQLILGESYTTGETFDSVSIRGIRLYSDSRMLPPTLASFAPIIHGVANTNAKVTIT
QGGYKIYETTVPPGAFVIDDLSPSGYGSDLIVTIEESDGSKRTFSQPFSSVVQMLRPGVG
RWDISGGQVLKDDIQDEPNLFQASYYYGLNNYLTGYTGIQITDNNYTAGLLGLGLNTSVG
AFSFDVTHSNVRIPDDKTYQGQSYRVSWNKLFEETSTSLNIAAYRYSTQNYLGLNDALTL
IDEVKHPEQDLEPKSMRNYSRMKNQVTVSINQPLKFEKKDYGSFYLSGSWSDYWASGQNR
SNYSIGYSNSTSWGSYSVSAQRSWNEDGDTDDSVYLSFTIPIEKLLGTEQRTSGFQSIDT
QISSDFKGNNQLNVSSSGYSDNARVSYSVNTGYTMNKASKDLSYVGGYASYESPWGTLAG
SISANSDNSRQVSLSTDGGFVLHSGGLTFSNDSFSDSDTLAVVQAPGAQGARINYGNSTI
DRWGYGVTSALSPYHENRIALDINDLENDVELKSTSAVAVPRQGSVVFADFETVQGQSAI
MNITRSDGKNIPFAADIYDEQGNVIGNVGQGGQAFVRGIEQQGNISIKWLEQSKPVSCLA
HYQQSPEAEKIAQSIILNGIRCQIQ
>sp|P20959|IBP3_BOVIN Insulin-like growth factor binding protein 3 precursor (IGFBP-3) 
MLRAPPRLWAAALTALTLLRGPPAARAGAGTMGAGPVVRCEPCDARAVAQCAPPPPSPPC
AELVRDAGCGCCLTCALREGQPCGVYTERCGSGLRCQPPPGDPRPLQALLDGRGLCANAS
AVGRLRPYLLPSASGNGSESEEDHSMGSTENQAGPSTHRVPVSKFHPIHTKMDVIKKGHA
KDSQRYKVDYESQSTDTQNFSSESKRETEYGPCRREMEDTLNHLKFLNMLSPRGIHIPNC
DKKGFYKKKQCRPSKGRKRGFCWCVDKYGQPLPGFDVKGKGDVHCYSMESK
>sp|P17085|IGF1_ONCKI Insulin-like growth factor I precursor (IGF-I) (Somatomedin). 
MSSGHLFQWHLCDVFKSAMCCISCTHTLSLLLCVLTLTSAATGAGPETLCGAELVDTLQF
VCGERGFYFSKPTGYGPSSRRSHNRGIVDECCFQSCELRRLEMYCAPVKSGKAARSVRAQ
RHTDMPRTPKVSTAVQNVDRGTERRTAQHPDKTKPKKEVHQKNSSRGNTGGRNYRM
>sp|P05017|IGFA_MOUSE Insulin-like growth factor IA precursor (IGF-IA) (Somatomedin). 
MSSSHLFYLALCLLTFTSSTTAGPETLCGAELVDALQFVCGPRGFYFNKPTGYGSSIRRA
PQTGIVDECCFRSCDLRRLEMYCAPLKPTKAARSIRAQRHTDMPKTQKEVHLKNTSRGSA
GNKTYRM
>sp|P40222|IL14_HUMAN Interleukin-14 precursor (IL-14) (High molecular weight B-cell growth 
MIRLLRSIIGLVLALPKGRGSDAKGLLTSTSSHAKTFSRSLVSRQEIPSSERPARLCLGT
PFLRSREVKVSLPEQLGGPELDLSKPCSSRQMQFNDLGVLLVLSSEGQGGVIEPQSQTEK
CSSHFCQLTVMAATDDSPSQDSSAHRQATDFICTHPHPQCKLHCTLTGINAFARPCKMPY
VRKTDPQKCQNCKCQMPARSEHAWLQQWAAQHGSLLWARLAGLPLPSQHDPTPGSLGPGG
GGLLRPVWPDASVLGCSWVARRFCDPGGAGCLMPQCPSGLLSGPLSVREPWPPALRSCTL
LFRSLRSVCSARHSFSSRWIFTCRPSSSLSRTVFSSAISSRALLLLSHRDRYMVVSFSSF
LIFLVIFSISCLNVVNTSLLLESVFWNSSNFSVYRASCCFRWVSCCFISSHILWDSTASF
RRKSFSRWCRSSASFSISWACWSLASTSCCCRSLCLKTLSICSSRSSYCSISFLSLSASS
MFSWRSLELRSLCCSICS
>sp|Q09024|IML2_DROME Neural/ectodermal development factor IMP-L2 precursor. 
MQKMNLHVCALALLLFGSIATVRGRAVDLVDDSNDVDNSIEAEEEKPRNRAFEADWLKFT
KTPPTKLQQADGATIEIVCEMMGSQVPSIQWVVGHLPRSELDDLDSNQVAEEAPSAIVRV
RSSHIIDHVLSEARTYTCVGRTGSKTIYASTVVHPPRSSRLTPEKTYPGAQKPRIIYTEK
THLDLMGSNIQLPCRVHARPRAEITWLNNENKEIVQGHRHRVLANGDLLISEIKWEDMGN
YKCIARNVVGKDTADTFVYPVLNEED
>sp|P01331|INS_PROGU Insulin. 
YVGQRLCGSQLVDTLYSVCKHRGFYRPSEGIVDQCCTNICSRNQLLTYCN
>sp|P12661|IRBP_BOVIN Interphotoreceptor retinoid-binding protein precursor (IRBP) 
MVRKWALLLPMLLCGLTGPAHLFQPSLVLEMAQVLLDNYCFPENLMGMQGAIEQAIKSQE
ILSISDPQTLAHVLTAGVQSSLNDPRLVISYEPSTLEAPPRAPAVTNLTLEEIIAGLQDG
LRHEILEGNVGYLRVDDIPGQEVMSKLRSFLVANVWRKLVNTSALVLDLRHCTGGHVSGI
PYVISYLHPGSTVSHVDTVYDRPSNTTTEIWTLPEALGEKYSADKDVVVLTSSRTGGVAE
DIAYILKQMRRAIVVGERTVGGALNLQKLRVGQSDFFLTVPVSRSLGPLGEGSQTWEGSG
VLPCVGTPAEQALEKALAVLMLRRALPGVIQRLQEALREYYTLVDRVPALLSHLAAMDLS
SVVSEDDLVTKLNAGLQAVSEDPRLQVQVVRPKEASSGPEEEAEEPPEAVPEVPEDEAVR
RALVDSVFQVSVLPGNVGYLRFDSFADASVLEVLGPYILHQVWEPLQDTEHLIMDLRQNP
GGPSSAVPLLLSYFQSPDASPVRLFSTYDRRTNITREHFSQTELLGRPYGTQRGVYLLTS
HRTATAAEELAFLMQSLGWATLVGEITAGSLLHTHTVSLLETPEGGLALTVPVLTFIDNH
GECWLGGGVVPDAIVLAEEALDRAQEVLEFHRSLGELVEGTGRLLEAHYARPEVVGQMGA
LLRAKLAQGAYRTAVDLESLASQLTADLQEMSGDHRLLVFHSPGEMVAEEAPPPPPVVPS
PEELSYLIEALFKTEVLPGQLGYLRFDAMAELETVKAVGPQLVQLVWQKLVDTAALVVDL
RYNPGSYSTAVPLLCSYFFEAEPRRHLYSVFDRATSRVTEVWTLPHVTGQRYGSHKDLYV
LVSHTSGSAAEAFAHTMQDLQRATIIGEPTAGGALSVGIYQVGSSALYASMPTQMAMSAS
TGEAWDLAGVEPDITVPMSVALSTARDIVTLRAKVPTVLQTAGKLVADNYASPELGVKMA
AELSGLQSRYARVTSEAALAELLQADLQVLSGDPHLKTAHIPEDAKDRIPGIVPMQIPSP
EVFEDLIKFSFHTNVLEGNVGYLRFDMFGDCELLTQVSELLVEHVWKKIVHTDALIVDMR
FNIGGPTSSISALCSYFFDEGPPILLDKIYNRPNNSVSELWTLSQLEGERYGSKKSMVIL
TSTLTAGAAEEFTYIMKRLGRALVIGEVTSGGCQPPQTYHVDDTDLYLTIPTARSVGAAD
GSSWEGVGVVPDVAVPAEAALTRAQEMLQHTPLRARRSPRLHGRRKGHHRQSQGRAGSLG
RNQGVVRPEVLTEAPSGQKRGLLQCG
>sp|P05106|ITB3_HUMAN Integrin beta-3 precursor (Platelet membrane glycoprotein IIIa) 
MRARPRPRPLWVTVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLG
SPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRP
DDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFG
AFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSR
NRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCH
VGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLS
MDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDT
VSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGT
FECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFG
KITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLL
CSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDREPYMTENTCNRY
CRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDIL
VVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTF
TNITYRGT
>sp|P01045|KNH2_BOVIN Kininogen, HMW II precursor (Thiol proteinase inhibitor) [Contains: 
MKLITILFLCSRLLPSLTQESSQEIDCNDQDVFKAVDAALTKYNSENKSGNQFVLYRITE
VARMDNPDTFYSLKYQIKEGDCPFQSNKTWQDCDYKDSAQAATGQCTATVAKRGNMKFSV
AIQTCLITPAEGPVVTAQYECLGCVHPISTKSPDLEPVLRYAIQYFNNNTSHSHLFDLKE
VKRAQKQVVSGWNYEVNYSIAQTNCSKEEFSFLTPDCKSLSSGDTGECTDKAHVDVKLRI
SSFSQKCDLYPGEDFLPPMVCVGCPKPIPVDSPDLEEALNHSIAKLNAEHDGTFYFKIDT
VKKATVQVVGGLKYSIVFIARETTCSKGSNEELTKSCEINIHGQILHCDANVYVVPWEEK
VYPTVNCQPLGQTSLMKRPPGFSPFRSVQVMKTEGSTTVSLPHSAMSPVQDEERDSGKEQ
GPTHGHGWDHGKQIKLHGLGLGHKHKHDQGHGHHRSHGLGHGHQKQHGLGHGHKHGHGHG
KHKNKGKNNGKHYDWRTPYLASSYEDSTTSSAQTQEKTEETTLSSLAQPGVAITFPDFQD
SDLIATVMPNTLPPHTESDDDWIPDIQTEPNSLAFKLISDFPETTSPKCPSRPWKPVNGV
NPTVEMKESHDFDLVDALL
>sp|P08932|KNT2_RAT T-kininogen II precursor (Major acute phase protein) (Alpha-1-MAP) 
MKLITILLLCSRLLPSLAQEEGAQELNCNDETVFQAVDTALKKYNAELESGNQFVLYRVT
KGTKKDGAETLYSFKYQIKEGNCSVQSGLTWQDCDFKDAEEAATGECTTTLGKKENKFSV
ATQICNITPGKGPKKTEEDLCVGCFQPIPMDSSDLKPVLKHAVEHSNNNTKHTHLFALRE
VKSAHSQVVAGMNYKIIYSIVQTNCSKEDFPSLREDCVPLPYGDHGECTGHTHVDIHNTI
AGFSQSCDLYPGDDLFSLLPKKCFGCPKNIPVDSPELKEALGHSIAQLNAQHNHLFYFKI
DTVKKATSQVVAGTKYVIEFIARETNCSKQTNTELTADCETKHLGQSLNCNANVYMRPWE
NKVVPTVRCQALDMMISRPPGFSPFRLVQVQETKEGTTRLLNSCEYKGRLSKAGAGPAPD
HQAEASTVTP
>sp|P33577|LAMR_PETMA Lamprin 1.8-10 precursor (Cartilage matrix protein). 
MAATMQALLVIALLHLATATPVVTKHKVSTFSTGFLGHPVGGLGYGGLGYGGLGYGGLGV
AGLGYGGLGYPGAALGGAYTHHAALGGLGYPLGIGAGVVAPHVVNSKIAAPLAPVVAAI
>sp|P36501|LANA_STRPY Lantibiotic streptococcin A-FF22 precursor (Antibacterial peptide 
MEKNNEVINSIQEVSLEELDQIIGAGKNGVFKTISHECHLNTWAFLATCCS
>sp|P15917|LEF_BACAN Lethal factor precursor (EC 3.4.24.-) (LF) (Anthrax lethal toxin 
MNIKKEFIKVISMSCLVTAITLSGPVFIPLVQGAGGHGDVGMHVKEKEKNKDENKRKDEE
RNKTQEEHLKEIMKHIVKIEVKGEEAVKKEAAEKLLEKVPSDVLEMYKAIGGKIYIVDGD
ITKHISLEALSEDKKKIKDIYGKDALLHEHYVYAKEGYEPVLVIQSSEDYVENTEKALNV
YYEIGKILSRDILSKINQPYQKFLDVLNTIKNASDSDGQDLLFTNQLKEHPTDFSVEFLE
QNSNEVQEVFAKAFAYYIEPQHRDVLQLYAPEAFNYMDKFNEQEINLSLEELKDQRMLSR
YEKWEKIKQHYQHWSDSLSEEGRGLLKKLQIPIEPKKDDIIHSLSQEEKELLKRIQIDSS
DFLSTEEKEFLKKLQIDIRDSLSEEEKELLNRIQVDSSNPLSEKEKEFLKKLKLDIQPYD
INQRLQDTGGLIDSPSINLDVRKQYKRDIQNIDALLHQSIGSTLYNKIYLYENMNINNLT
ATLGADLVDSTDNTKINRGIFNEFKKNFKYSISSNYMIVDINERPALDNERLKWRIQLSP
DTRAGYLENGKLILQRNIGLEIKDVQIIKQSEKEYIRIDAKVVPKSKIDTKIQEAQLNIN
QEWNKALGLPKYTKLITFNVHNRYASNIVESAYLILNEWKNNIQSDLIKKVTNYLVDGNG
RFVFTDITLPNIAEQYTHQDEIYEQVHSKGLYVPESRSILLHGPSKGVELRNDSEGFIHE
FGHAVDDYAGYLLDKNQSDLVTNSKKFIDIFKEEGSNLTSYGRTNEAEFFAEAFRLMHST
DHAERLKVQKNAPKTFQFINDQIKFIINS
>sp|P49012|LIG2_PHACH Ligninase LG2 precursor (EC 1.11.1.-) (Lignin peroxidase). 
MAFKQLFAAITVALSLTAANAAVVKEKRATCANGKTVGDASCCAWFDVLDDIQANMFHGG
QCGAEAHESIRLVFHDSIAISPAMEAKGKFGGGGADGSIMIFDTIETAFHPNIGLDEVVA
MQKPFVQKHGVTPGDFIAFAGAVALSNCPGAPQMNFFTGRKPATQPAPDGLVPEPFHTVD
QIIARVNDAGEFDELELVWMLSAHSVAAVNDVDPTVQGLPFDSTPGIFDSQFFVETQFRG
TLFPGSGGNQGEVESGMAGEIRIQTDHTLARDSRTACEWQSFVGNQSKLVDDFQFIFLAL
TQLGQDPNAMTDCSDVIPLSKPIPGNGPFSFFPPGKSHSDIEQACAETPFPSLVTLPGPA
TSVARIPPHKA
>sp|P23132|LITH_BOVIN Lithostathine precursor (Pancreatic stone protein) (PSP) (Pancreatic 
MLPSLGLPRLSWMLLSCLMLLSQIQGENSQKELPSARISCPSGSMAYRSHCYALFKTPKT
WMDADIACQKRPSGHLVSVLSGAEESFVASLVRNNLNTQSDIWIGLHDPTEGSEANAGGW
EWISNDVLNYVAWETDPAAISSPGYCGSLSRSSGYLKWRDHNCNLNLPYVCKFTD
>sp|P25391|LMA1_HUMAN Laminin alpha-1 chain precursor (Laminin A chain). 
MRGGVLLVLLLCVAAQCRQRGLFPAILNLASNAHISTNATCGEKGPEMFCKLVEHVPGRP
VRNPQCRICDGNSANPRERHPISHAIDGTNNWWQSPSIQNGREYHWVTITLDLRQVFQVA
YVIIKAANAPRPGNWILERSLDGTTFSPWQYYAVSDSECLSRYNITPRRGPPTYRADDEV
ICTSYYSRLVPLEHGEIHTSLINGRPSADDLSPKLLEFTSARYIRLRLQRIRTLNADLMT
LSHREPKELDPIVTRRYYYSIKDISVGGMCICYGHASSCPWDETTKKLQCQCEHNTCGES
CNRCCPGYHQQPWRPGTVSSGNTCEACNCHNKAKDCYYDESVAKQKKSLNTAGQFRGGGV
CINCLQNTMGINCETCIDGYYRPHKVSPYEDEPCRPCNCDPVGSLSSVCIKDDLHSDLHN
GKQPGQCPCKEGYTGEKCDRCQLGYKDYPTCVSCGCNPVGSASDEPCTGPCVCKENVEGK
ACDRCKPGFYNLKEKNPRGCSECFCFGVSDVCSSLSWPVGQVNSMSGWLVTDLISPRKIP
SQQDALGGRHQVSINNTAVMQRLAPKYYWAAPEAYLGNKLTAFGGFLKYTVSYDIPVETV
DSNLMSHADVIIKGNGLTLSTQAEGLSLQPYEEYLNVVRLVPENFQDFHSKRQIDRDQLM
TVLANVTHLLIRATYNSAKMALYRLESVSLDIASSNAIDLVVAADVEHCECPQGYTGTSC
ESCLSGYYRVDGILFGGICQPCECHGHAAECNVHGVCIACAHNTTGVHCEQCLPGFYGEP
SRGTPGDCQPCACPLTIASNNFSPTCHLNDGDEVVCDWCAPGYSGAWCERCADGYYGNPT
VPGESCVPCDCSGNVDPSEAGHCDSVTGECLKCLGNTDGAHCERCADGFYGDAVTAKNCR
ACECHVKGSHSAVCHLETGLCDCKPNVTGQQCDQCLHGYYGLDSGHGCRPCNCSVAGSVS
DGCTDEGQCHCVPGVAGKRCDRCAHGFYAYQDGSCTPCDCPHTQNTCDPETGECVCPPHT
QGGKCEECEDGHWGYDAEVGCQACNCSLVGSTHHRCDVVTGHCQCKSKFGGRACDQCSLG
YRDFPDCVPCDCDLRGTSGDACNLEQGLCGCVEETGACPCKENVFGPQCNECREGTFALR
ADNPLGCSPCFCSGLSHLCSELEDYVRTPVTLGSDQPLLRVVSQSNLRGTTEGVYYQAPD
FLLDAATVRQHIRAEPFYWRLPQQFQGDQLMAYGGKLKYSVAFYSLDGVGTSNFEPQVLI
KGGRIRKQVIYMDAPAPENGVRQEQEVAMRENFWKYFNSVSEKPVTREDFMSVLSDIEYI
LIKASYGQGLQQSRISDISVEVGRKAEKLHPEEEVASLLENCVCPPGTVGFSCQDCAPGY
HRGKLPAGSDRGPRPLVAPCVPCSCNNHSDTCDPNTGKCLNCGDNTAGDHCDVCTSGYYG
KVTGSASDCALCACPHSPPASFSPTCVLEGDHDFRCDACLLGYEGKHCERCSSSYYGNPQ
TPGGSCQKCDCNRHGSVHGDCDRTSGQCVCRLGASGLRCDECEPRHILMETDCVSCDDEC
VGVLLNDLDEIGDAVLSLNLTGIIPVPYGILSNLENTTKYLQESLLKENMQKDLGKIKLE
GVAEETDNLQKKLTRMLASTQKVNRATERIFKESQDLAVAIERLQMSITEIMEKTTLNQT
LDEDFLLPNSTLQNMQQNGTSLLEIMQIRDFTQLHQNATLELKAAEDLLSQIQENYQKPL
EELEVLKEAASHVLSKHNNELKAAEALVREAEAKMQESNHLLLMVNANLREFSDKKLHVQ
EEQNLTSELIVQGRGLIDAAAAQTDAVQDALEHLEDHQDKLLLWSAKIRHHIDDLVMHMS
QRNAVDLVYRAEDHATEFQRLADVLYSGLENIRNVSLNATSAAYVHYNIQSLIEESEELA
RDAHRTVTETSLLSESLVSNGKAAVQRSSRFLKEGNNLSRKLPGIALELSELRNKTNRFQ
ENAVEITRQTNESLLILRAIPEGIRDKGAKTKELATSASQSAVSTLRDVAGLSQELLNTS
ASLSRVNTTLRETHQLLQDSTMATLLAGRKVKDVEIQANLLFDRLKPLKMLEENLSRNLS
EIKLLISQARKQAASIKVAVSADRDCIRAYQPQISSTNYNTLTLNVKTQEPDNLLFYLGS
STASDFLAVEMRRGRVAFLWDLGSGSTRLEFPDFPIDDNRWHSIHVARFGNIGSLSVKEM
SSNQKSPTKTSKSPGTANVLDVNNSTLMFVGGLGGQIKKSPAVKVTHFKGCLGEAFLNGK
SIGLWNYIEREGKCRGCFGSSQNEDPSFHFDGSGYSVVEKSLPATVTQIIMLFNTFSPNG
LLLYLGSYGTKDFLSIELFRGRVKVMTDLGSGPITLLTDRRYNNGTWYKIAFQRNRKQGV
LAVIDAYNTSNKETKQGETPGASSDLNRLDKDPIYVGGLPRSRVVRRGVTTKSFVGCIKN
LEISRSTFDLLRNSYGVRKGCLLEPIRSVSFLKGGYIELPPKSLSPESEWLVTFATTNSS
GIILAALGGDVEKRGDREEAHVPFFSVMLIGGNIEVHVNPGDGTGLRKALLHAPTGTCSD
GQAHSISLVRNRRIITVQLDENNPVEMKLGTLVESRTINVSNLYVGGIPEGEGTSLLTMR
RSFHGCIKNLIFNLELLDFNSAVGHEQVDLDTCWLSERPKLAPDAEDSKLLREPRAFPEQ
CVVDAALEYVPGAHQFGLTQNSHFILPFNQSAVRKKLSVELSIRTFASSGLIYYMAHQNQ
ADYAVLQLHGGRLHFMFDLGKGRTKVSHPALLSDGKWHTVKTDYVKRKGFITVDGRESPM
VTVVGDGTMLDVEGLFYLGGLPSQYQARKIGNITHSIPACIGDVTVNSKQLDKDSPVSAF
TVNRCYAVAQEGTYFDGSGYAALVKEGYKVQSDVNITLEFRTSSQNGVLLGISTAKVDAI
GLELVDGKVLFHVNNGAGRITPAYEPKTATVLCDGKWHTLQANKSKHRITLIVDGNAVGA
ESPHTQSTSVDTNNPIYVGGYPAGVKQKCLRSQTSFRGCLRKLALIKSPQVQSFDFSRAF
ELHGVFLHSCPGTES
>sp|P15800|LMB2_RAT Laminin beta-2 chain precursor (S-laminin) (Laminin chain B3). 
MEWASGKPGRGRQGQPVPWELRLGLLLSVLAATLAQVPSLDVPGCSRGSCYPATGDLLVG
RADRLTASSTCGLHSPQPYCIVSHLQDEKKCFLCDSRRPFSARDNPNSHRIQNVVTSFAP
QRRTAWWQSENGVPMVTIQLDLEAEFHFTHLIMTFKTFRPAAMLVERSADFGRTWRVYRY
FSYDCGADFPGIPLAPPRRWDDVVCESRYSEIEPSTEGEVIYRVLDPAIPIPDPYSSRIQ
NLLKITNLRVNLTRLHTLGDNLLDPRREIREKYYYALYELVIRGNCFCYGHASQCAPAPG
APAHAEGMVHGACICKHNTRGLNCEQCQDFYQDLPWHPAEDGHTHACRKCECNGHSHSCH
FDMAVYLASGNVSGGVCDGCQHNTAGRHCELCRPFFYRDPTKDMRDPAACRPCDCDPMGS
QDGGRCDSHDDPVLGLVSGQCRCKEHVVGTRCQQCRDGFFGLSASNPRGCQRCQCNSRGT
VPGGTPCDSSSGTCFCKRLVTGDGCDRCLPGHWGLSHDLLGCRPCDCDVGGALDPQCDEA
TGQCPCRPHMIGRRCEQVQPGYFRPFLDHLTWEAEGAHGQVLEVVERLVTNRETPSWTGV
GFVRLREGQEVEFLVTSLPRAMDYDLLLRWEPQVPEQWAELELVVQRPGPVSAHSPCGHV
LPRDDRIQGMLHPNTRVLVFPRPVCLEPGLSYKLKLKLTGTGGRAHPETPYSGSGILIDS
LVLQPHVLMLEMFSGGDAAALERRTTFERYRCHEEGLMPSKTPLSEACVPLLISASSLVY
NGALPCQCDPQGSLSSECNPHGGQCRCKPGVVGRRCDACATGYYGFGPAGCQACQCSPDG
ALSALCEGTSGQCLCRTGAFGLRCDHCQRGQWGFPNCRPCVCNGRADECDAHTGACLGCR
DYTGGEHCERCIAGFHGDPRLPYGGQCRPCPCPEGPGSQRHFATSCHRDGYSQQIVCHCR
AGYTGLRCEACAPGHFGDPSKPGGRCQLCECSGNIDPTDPGACDPHTGQCLRCLHHTEGP
HCGHCKPGFHGQAARQSCHRCTCNLLGTDPQRCPSTDLCHCDPSTGQCPCLPHVQGLSCD
RCAPNFWNFTSGRGCQPCACHPSRARGPTCNEFTGQCHCHAGFGGRTCSECQELHWGDPG
LQCRACDCDPRGIDKPQCHRSTGHCSCRPGVSGVRCDQCARGFSGVFPACHPCHACFGDW
DRVVQDLAARTRRLEQWAQELQQTGVLGAFESSFLNLQGKLGMVQAIVAARNTSAASTAK
LVEATEGLRHEIGKTTERLTQLEAELTDVQDENFNANHALSGLERDGLALNLTLRQLDQH
LDILKHSNFLGAYDSIRHAHSQSTEAERRANASTFAIPSPVSNSADTRRRAEVLMGAQRE
NFNRQHLANQQALGRLSTHTHTLSLTGVNELVCGAPGDAPCATSPCGGAGCRDEDGQPRC
GGLGCSGAAATADLALGRARHTQAELQRALVEGGGILSRVSETRRQAEEAQQRAQAALDK
ANASRGQVEQANQELRELIQNVKDFLSQEGADPDSIEMVATRVLDISIPASPEQIQRLAS
EIAERVRSLADVDTILAHTMGDVRRAEQLLQDAQRARSRAEGERQKAETVQAALEEAQRA
QGAAQGAIRGAVVDTKNTEQTLQQVQERMAGTEQSLNSASERARQLHALLEALKLKRAGN
SLAASTAEETAGSAQSRAREAEKQLREQVGDQYQTVRALAERKAEGVLAAQARAEQLRDE
ARGLLQAAQDKLQRLQELEGTYEENERELEVKAAQLDGLEARMRSVLQAINLQVQIYNTC
Q
>sp|P15215|LMG1_DROME Laminin gamma-1 chain precursor (Laminin B2 chain). 
MKRSRWSHSGSSTARLLLIGVLFASCSTAILGAQRPPINSAGGHELRGTTFMPALECYDP
YGRPQKCLPEFINAAYQLQIESTNTCGEQNDNHFCIQTMNQNHKNCEFCKYNDHNPSFLT
DLHDPQSPTWWQSETMFEGIQHPNYVNLTLHLGKSYDITYVRILFRSPRPESFTIYKRTS
ESGPWIPYQFYSATCRDTYSLPDSRAIRKGEGEAHALCTSEYSDISPLRDGEIAFSTLEG
RPSGINFERSGELQEWVTATDIRITLDRLNTFGDELFGDSQVLKSYFYAISDIAVGARCK
CNGHASKCVPSTGMHGERTLVCECRHNTDGPDCDRCLPLYNDLKWKRSTSTEVNECKACN
CNGLADKCFFDANLFNRTGHGGHCLDCRENRDGPNCERCKENFYMRDDGYCVNCACDPVG
SRSLQCNSHGKCQCKPGVTGDKCDRCDNNYYQFGPHGCQQCGCDSGGSHQNTPACDTETG
ICFCKENVEGRRCNECKPGFFNLDKNNRFGCTPCFCYGHTSECMTAPGYSIVSVTSNFNK
FKERWTAADLNQREVDIKYNQYSRSIGTTAQGNEHVYFQAPDRFLGDQRASYNRDLKFKL
QLVGQVANTGVSDVILEGAGSRISLPIFAQGNGIPDQGVKEYTFRLHEHHDYQWQPSQSA
RGFLSILSNLTAIKIRATYSVQGEAILDDVELQTAHRGAAGHPATWIEQCTCPEGYLGQF
CESCAPGYRHSPARGGPFMPCIPCDCHGHADICDSETGRCICQHNTHGDNCDQCAKGFYG
NALGGTPNDCKRCPCPNDGACLQINEDTVICTECPKGYFGSRCEQCSDGFFGDPTGLLGE
VQTCKSCDCNGNVDPNAVGNCNRTTGECLKCIHNTAGEHCDQCLSGHFGDPLALPHGRCD
RCSCYEAGTEQDEQSITRCDQVTGQCQCKPNVIGRDCGECQPGYFNIRSGNGCENCLCDP
VGSYNSTCDRYSGQCHCRPGVMGQRCDQCENYFYGFSSEGCKPCECDESGSKGFQCDQNG
QCPCNDNVEGRRCDRCKENKYDRHRGCIDCPDCYNLVQDAADLHRAKLFNLSQTLDEIAR
TPVTNDDEFEAKLKAVQEKVAVLAQDARDNSGDGGQTYAEVIDDLHKHLDSVREHLVSAD
KFQADANGEIDRARQNYTILDQITENAKKELQQALDLLNDEGAQALARAKEKSVEFGQQS
EQISDISREARALADKLESEAQFDLKNAKDAKDAVEKAHQLAKSAIDLQLKIGTELRSEV
GLELSHVKQSLGTVVQTSKEALRKANEVYDTALTLLNDVNRQTQPEIDISQLKKDAVAAN
ERADELLKQITELSNSNGELFADFETEQELTEALLKRAEQQQLEDIELLERAKAAHDKAT
KAVEQGDNTLKEANNTYEKLAGFQSDVQRSSESAEKALQTVPNIEKEIQNAESLISQAEE
ALDGANKNANEAKKNAQEAQLKYAEQASKDAELIRRKANETKVAARNLREEADQLNHRVK
LTEMDIFKLEESSTKDDNLVDDAKRKVGQAKADTQEAQKQIEKANADLTAIKDELENLKD
INTGDLDRLENRLATVEGEINRVNLTGRIEKYREQRTIQKNLIDKYDAELRELKDEVQNI
GLISKALPDSCFSRNRLEP
>sp|P36685|LPPB_HAESO Outer membrane antigenic lipoprotein B precursor (Fragment). 
MKKFLPLSISITVLAACSSHTPAPVENAKDLAPSIIKPINGTNSTAWEPQVIQQKMPESM
RVPKATNSTYQPEIIQQNQQKTESIAKKQALQNFEIPRDPKTNVPVYSKIDKGFYKGDTY
KVRKGDTMFLIAYISGMDIKELATLNNMSEPYHLSIGQVLKIANNIPDSNMIPTQTINES
EVTQNTVNETWNANKPTNEQMKPVATPTHSTMPINKTPPATSNIAWIWPTNGKIIQGFSS
ADGGNKGIDISGSRGQAVNAAAAGRVVYAGDALRGYGNLIIIKHNDSYLSAYAHNESILV
KDQQEVKAGQQIAKMGSSGTNTIKLHFXIRYFGQSVD
>sp|P26305|LPSB_PERAM Hemolymph lipopolysaccharide-binding protein precursor (LPS-binding 
MMNTRALLPLSVLLMATLCLCELPIPILQRFVRSVPEECPIADPSDFKFSITSNRNKTGH
WTAQVRLEHGEHEQSGSNQHNRDLWQVDLEQTTTTCAGVKSVQIITTITAPPPTAAPSIP
PGYELSAVLGYYKFHKTPKTWDEARIICQQEGGHLVIINSEDESKVLQNLFSKVTKTEGA
TNNDYIFIGIHDRFVEGEFITIFGKPLATTGFTRWVDSIQPDNAGGNENCGSMHPNGGLN
DIPCPWKLPFVCEVEL
>sp|P25310|LYCM_STRGL Lysozyme M1 precursor (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase M1). 
MPAYSSLARRGRRPAVVLLGGLVSASLALTLAPTAAAAPLAPPPGKDVGPGEAYMGVGTR
IEQGLGAGPDERTIGPADTSGVQGIDVSHWQGSINWSSVKSAGMSFAYIKATEGTNYKDD
RFSANYTNAYNAGIIRGAYHFARPNASSGTAQADYFASNGGGWSRDNRTLPGVLDIEHNP
SGAMCYGLSTTQMRTWINDFHARYKARTTRDVVIYTTASWWNTCTGSWNGMAAKSPFWVA
HWGVSAPTVPSGFPTWTFWQYSATGRVGGVSGDVDRNKFNGSAARLLALANNTA
>sp|P28716|MER4_EUPOC Mating pheromone 4 precursor. 
MKAIFIILAILMVTQAFKMTSKVKSMNMSRNMSKNTSTLGTKYTYGCPQTNTPTQQDCYD
AMYYTFMAMCDLYPDPEHPMFPSYDSCQEESDSADEFYTNQCGCGGYGMAAAHDQVCLLA
LGVCIPE
>sp|Q04900|MG24_HUMAN Putative mucin core protein 24 precursor (MULTI-glycosylated core 
MSRLSRSLLWAATCLGVLCVLSADKNTTQHPNVTTLAPISNVTSAPVTSLPLVTTPAPET
CEGRNSCVSCFNVSVVNTTCFWIECKDESYCSHNSTVSDCQVGNTTDFCSVSTATPVPTA
NSTAKPTVQPSPSTTSKTVTTSGTTNNTVTPTSQPVRKSTFDAASFIGGIVLVLEIRCHT
RNYIPDLKK
>sp|P10667|MUA1_XENLA Integumentary mucin A.1 precursor (FIM-A.1) (Preprospasmolysin). 
MKHIILCIHFLLMVVGLGQAQDCSVAPNMRVNCGYPTVTEADCRAVGCCFDSSILNTKWC
FYNATAGPIKKLECSGDPTKRIDCGFPRITEKQCILRGCCFDSSISGVKWCYARTVITTP
APDTTTASTTAETTTVPTTPETTTVPTTPETTTVPTTPETTTVPTTPETTTVPTTPETTT
VPTTPETTTVPTTPETTTVPTTPETTTVPTTPETTTVPTTPETTTVPTTPETTTASTTAE
TTTVPTTPETTTEPTTTPTTDTTPPTLPPTPETTTETTTETTTETTTETTTETTTETTTA
PPPECAADRVDCGYSGITQADCEGKGCIFDSTIPETKWCFYTEAEAPARKAECTVDPSVR
TDCGYPGITDKECREKGCCYDECIPDVIWCFEKAVPVVNS
>sp|P20910|MYCO_STRCI Mycolysin precursor (EC 3.4.24.31) (Neutral metalloproteinase) (NPR) 
MPMFRIRLPKPAALIAAGGIGACIATVAVPSAYAAAPAPADSRLGVTASLDRLPSIGERS
TLTVNITAETDVKRAGLSLQLPPALRIVDRNPSLAAPTTDPFGQRTSRTLTLTPGTRTIE
LEVKAVATGPAQIQADISDIDRPDPRRAGHASVELTIGKAKGSTAKGMSVTKADATPVSG
PTTPGRPVRPGAAAPAAPSTPPQAAAPGKRYAPVCVSGTLRNRFQSSEGGSWNSKASRDL
PVSNANVTLWGRATAGGGTQKLAAGLTGNGDGTFKLCYTPSTSVTSQVWAEFQTQAGTMW
SVVDGYNRRYSTTSNALSNVSGNKSLGTVYANSGQSRAWHAFDTLNKLWWDRGSTSTCWT
SNQRDGRCTPITVQWYPGSTDGTYWTNRDDKVHLADSDPDSGHTTVHEAGHSLMGKLYNG
WWPYVTNCSPHYINRTSSTTCGWTEGFADAVAFHTFKDTVMTWGNGSSMNLANDRGTRGM
DWGDACEARVGTALVDLWSQVDGGWTKSNTMMSRERQSTFREYFLTDRPAYGLDSGPKAR
NILYGHTIQY
>sp|P40710|CUTF_ECOLI Copper homeostasis protein cutF precursor (Lipoprotein nlpE). 
MVKKAIVTAMAVISLFTLMGCNNRAEVDTLSPAQAAELKPMPQSWRGVLPCADCEGIETS
LFLEKDGTWVMNERYLGAREEPSSFASYGTWARTADKLVLTDSKGEKSYYRAKGDALEML
DREGNPIESQFNYTLEAAQSSLPMTPMTLRGMYFYMADAATFTDCATGKRFMVANNAELE
RSYLAARGHSEKPVLLSVEGHFTLEGNPDTGAPTKVLAPDTAGKFYPNQDCSSLGQ
>sp|P24289|NUP1_PENCI Nuclease P1 (EC 3.1.30.1) (Endonuclease P1) (Deoxyribonuclease P1). 
WGALGHATVAYVAQHYVSPEAASWAQGILGSSSSSYLASIASWADEYRLTSAGKWSASLH
FIDAEDNPPTNCNVDYERDCGSSGCSISAIANYTQRVSDSSLSSENHAEALRFLVHFIGD
MTQPLHDEAYAVGGNKINVTFDGYHDNLHSDWDTYMPQKLIGGHALSDAESWAKTLVQNI
ESGNYTAQAIGWIKGDNISEPITTATRWASDANALVCTVVMPHGAAALQTGDLYPTYYDS
VIDTIELQIAKGGYRLANWINEIHGSEIAK
>sp|P25031|PAP1_RAT Pancreatitis-associated protein 1 precursor (Peptide 23) (REG-2). 
MLHRLAFPVMSWMLLSCLMLLSQVQGEDSPKKIPSARISCPKGSQAYGSYCYALFQIPQT
WFDAELACQKRPEGHLVSVLNVAEASFLASMVKNTGNSYQYTWIGLHDPTLGGEPNGGGW
EWSNNDIMNYVNWERNPSTALDRGFCGSLSRSSGFLRWRDTTCEVKLPYVCKFTG
>sp|P35231|PAP2_RAT Pancreatitis-associated protein 2 precursor (Lithostathine 3) (Islet 
MLPRLSFNNVSWTLLYYLFIFQVRGEDSQKAVPSTRTSCPMGSKAYRSYCYTLVTTLKSW
FQADLACQKRPSGHLVSILSGGEASFVSSLVTGRVNNNQDIWIWLHDPTMGQQPNGGGWE
WSNSDVLNYLNWDGDPSSTVNRGNCGSLTATSEFLKWGDHHCDVELPFVCKFKQ
>sp|P35336|PGLR_ACTCH Polygalacturonase precursor (EC 3.2.1.15) (PG) (Pectinase). 
MALQRRFFQFVIITLLIPSFILGYTSAVHEDPPHDYHLEEYGYDFKAYPSYITTIGDNDF
GSSMSHENGIFGLRKVDYGMDRVLDASKTVNVDDFGAKGDGRDDTKAFEKAWKAACSSTS
SAVLLVPKKNYLVRPISFSGPCKSGLTMQIYGTIEASDDRSDYRKDGRHWLVFDSVQNLR
VEGGGTINGNGKIWWQNSCKTNKALPCKDAPTALTFYKSKHVIVKNLKIENAQQIHVSFD
NCVNVQASNLMVTAPENSPNTDGIHVTGTQNIHISSCVIGTGDDCISIVNGSRKVRVNDI
TCGPGHGISIGSLGYGNSEAHVSDVVVNGAKLCGTTNGVRIKTWQGGSGSASNIKFQNVE
MHNVENPIIIDQNYCDQDKPCQEQSSAVQVKNVVYQNIKGTCASNVAITFDCSKRFPCQG
IVLEDVDLEIEGGAAAKALCNNVELSETGVVSPHCQEEGGEEEEEAS
>sp|P09599|PHL1_BACCE Sphingomyelinase C precursor (EC 3.1.4.12) (Sphingomyelin 
MKGKLLKGVLSFGIGLGVLYGGSSVQADTSTDQNNTLKVMTHNVYMLSTNLYPNWGQSQR
ADLIGAADYIKNQDVVILNEVFDNSASDRLLGNLKKEYPNQTAVLGRSNGNEWDKTLGSY
SSSTPEDGGVAIVSKWPIVEKIQYVFAKGCGPDNLSNKGFVYTKIKKNDRFVHVIGTHLQ
AEDSMCGKTSPASVRTNQLKEIQDFIKNKNIPNDEYVLFGGDMNVNKINAENNSDSEYAS
MFKTLHASIPSYTGHTATWDATTNSIAKYNFPDSPAEYLDYIIASKDHANPSFIENKVLQ
PKSPQWTVTSWLKKYTYDDYSDHYPVAATISMK
>sp|P80109|PHLD_BOVIN Phosphatidylinositol-glycan-specific phospholipase D precursor 
MSAFRFWSGLLMLLGFLCPRSSPCGISTHIEIGHRALEFLHLQDGSINYKELLLRHQDAY
QAGSVFPDSFYPSICERGQFHDVSESTHWTPFLNASVHYIRKNYPLPWDEDTEKLVAFLF
GITSHMVADVNWHSLGIEQGFLRTMAAIDFHNSYPEAHPAGDFGGDVLSQFEFKFNYLSR
HWYVPAEDLLGIYRELYGRIVITKKAIVDCSYLQFLEMYAEMLAISKLYPTYSVKSPFLV
EQFQEYFLGGLEDMAFWSTNIYHLTSYMLKNGTSNCNLPENPLFITCGGQQNNTHGSKVQ
KNGFHKNVTAALTKNIGKHINYTKRGVFFSVDSWTMDSLSFMYKSLERSIREMFIGSSQP
LTHVSSPAASYYLSFPYTRLGWAMTSADLNQDGYGDLVVGAPGYSHPGRIHVGRVYLIYG
NDLGLPRIDLDLDKEAHGILEGFQPSGRFGSAVAVLDFNVDGVPDLAVGAPSVGSEKLTY
TGAVYVYFGSKQGQLSSSPNVTISCQDTYCNLGWTLLAADVNGDSEPDLVIGSPFAPGGG
KQKGIVAAFYSGSSYSSREKLNVEAANWMVKGEEDFAWLGYSLHGVNVNNRTLLLAGSPT
WKDTSSQGHLFRTRDEKQSPGRVYGYFPPICQSWFTISGDKAMGKLGTSLSSGHVMVNGT
RTQVLLVGAPTQDVVSKVSFLTMTLHQGGSTRMYELTPDSQPSLLSTFSGNRRFSRFGGV
LHLSDLDNDGLDEIIVAAPLRITDATAGLMGEEDGRVYVFNGKQITVGDVTGKCKSWVTP
CPEEKAQYVLISPEAGSRFGSSVITVRSKEKNQVIIAAGRSSLGARLSGVLHIYRLGQD
>sp|P18121|PLL1_MOUSE Placental lactogen I precursor (PL-I). 
MQLTLNLSGSAGMQLLLLVSSLLLWENVSSKPTAMVPTEDLYTRLAELLHNTFILAADVY
REFDLDFFDKTWITDRTLPLCHTASIHTPENREEVHETKTEDLLKAMINVSISWKEPLKH
LVSALTALPGASESMGKKAADIKGRNLVILEGLQTIYNRSQANIEENENFDYPAWSGLEE
LQSPNEDTHLFAVYNLCRCIKRDIHKIDSYIKVLRCRVVFQNEC
>sp|P04769|PLFR_MOUSE Proliferin-related protein precursor (PRP). 
MLPSLIQPCSSGTLLMLLMSNLFLWEKVSSAPINASEAVLSDLKDLFDNATVLSGEMSKL
GVIMRKEFFMNSFSSETFNKIILDLHKSTENITKAFNSCHTVPINVPETVEDVRKTSFEE
FLKMVLHMLLAWKEPLKHLVTELSALPECPYRILSKAEAIEAKNKDLLEYIIRIISKVNP
AIKENEDYPTWSDLDSLKSADKETQFFALYMFSFCLRIDLETVDFLVNFLKCLLLYDDVC
YSEF
>sp|P10765|PRL_LOXAF Prolactin (PRL). 
IPVCPRGSVRCQVSLPDLFDRAVMLSHYIHSLSSDMFHEFNKQYALGRGFIPRAINSCHT
SSISTPEDKDQAQQTHHEVLMDLILGLLRSWNDPLDHLASEVHSLPKAPSALLTKATEVK
EENQRLLEGIEKIVDQVHPGAKENKAYSVWSGLPSLQTTDEDARLFAFYNLFRCLRRDSH
KIDSYLKLLKCRIVYNNNC
>sp|P21347|PROA_LEGPN Zinc metalloproteinase precursor (EC 3.4.24.-) (PEP1) (PRO A). 
MHPNYYLSPLAVAIALGIASPVKAADPIPLQKSSFSEVTQKFQLTLPGVMKGAVVSTNSL
QFIRQHTDGNKVTHVRMQQQYAGFPVFGGYAILHSKNATPSLATAKSDEKMNGVIYDGLQ
AELGQPKPSFVKNASMALQQFKDKYANKQVSEDQVTPMIYIDEKHQAHWAYKVSVLVIHD
DRIPERPTAIIDAETNKPFVQWDDVKTEKVQAKGMGFGGNRKIGEYQFGKDLPLLEITRD
SSVEMCFMENTDVKVVDMGHKYYSNNKPMQFTCKETPDTQSTKTYYTGYSADGYDRDNGA
ASPTNDALYAGYVIKHMYHDWYGVEALTKSDGSPMQLVMRVHYGQGYENAYWDGKQMTFG
DGDTMMYPLVSLGVGGHEVSHGFTEQHSGLEYFGQSGGMNESFSDMAAQAAEYYSVGKNS
WQIGPEIMKEDSGYDALRYMDKPSRDGMSIDVADDYYGGLDVHYSSGVYNHLFYILANQP
NWNLRMAFDVMVKANMDYWTPYSTFDEGGCGMLSAAKDLGYNLDDIKKSLSEVTINYQSC
YVD
>sp|P09879|PROB_STRAG Protein B (cAMP factor). 
DQVTTPQVVNHVNSNNQAQQMAQKLDQDSIQLRNIKDNVQGTDYEKPVNEAITSVEKLKT
SLRANSETVYDLNSIGSRVEALTDVIEAITFSTQHLANKVSQANIDMGFGITKLVIRILD
PFASVDSIKAQVNDVKALEQKVLTYPDLKPTDRATIYTKSKLDKEIWNTRFTRDKKVLNV
KEFKVYNTLNKAITHAVGVQLNPNVTVQQVDQEIVTLQAALQTALK
>sp|P05402|PRR1_BOVIN Placental prolactin-related protein I precursor (PRC-I). 
MAPAPSFRGHQWTYNPVRGSCLLLLLLMSNLLLCQGKSCPSCGPDVFVSLRKSFTDRFMN
AASLSHDFYNLSTIMFNEFDEKYAQGKLYYINVTKSCHTNSFHAPEERDIVQQTNIEDLS
KWTLVLLYSWNNPLHHLVTELQHMKELSNAFLSSATRFENMSEKLQAFIERQFSKIIVPV
LNTMIQARSSWTGLPSLMSSAEDRRHSEFYNLFYCLRRDSRKVDMYIKILTCRTHKTC
>sp|P07224|PRTS_BOVIN Vitamin K-dependent protein S precursor. 
MRVLGGRTGTLLACLALVLPVLEANFLSRQHASQVLIRRRRANTLLEETKKGNLERECIE
ELCNKEEAREIFENNPETEYFYPKYLGCLGSFRAGLFTAARLSTNAYPDLRSCVNAISDQ
CNPLPCNEDGFMTCKDGQATFTCICKSGWQGEKCESDINECKDPVNINGGCSQICENTPG
SYHCSCKNGFVMLSNKKDCKDVDECVLKPSICGTAVCKNIPGDFECECAEGYKYNPVSKS
CDDVDECAENLCAQLCVNYPGGYSCYCDGKKGFKLAQDQKSCEAVPVCLPLDLDKNYELL
YLAEQFVGVVLYLKFRLPETTRFSAEFDFRTYDSEGVILYAESSDHSAWFLIALREGKIE
IQFKNEKTTKMTTGGKVINDGLWHMVSVEELEQSISVKIAKEAVMNINKPGSLFKPTNGF
LETKVYFAGVPRKMENALIRPINPRLDGCIRGWNLMNQGTSGVKEIIQEKQNKHCLVNVE
KGSYYPGTGVAQFSINYKNESNPEAWQINVSLNIRPSAGTGVMLALVSDNTVPFALSLVD
SATEKLQDILVSVESMVIGRIEAISLCSDQQTFLEIRVNRNNLELSTQLRKDSFHSEDFQ
RQFAILDEAMKGTVVTYLGGLPDVPFSATPVNAFYQGCMEVNINGVQVDLDEAISKHNDI
RAHSCPSVWQKTKHT
>sp|P22355|PSPB_RAT Pulmonary surfactant-associated protein B precursor (SP-B) (Pulmonary 
MAKLHLQWLLLLPTLCSLGAATESASSPDCAQGPKFWCQSLEQAIQCRALGHCLQEVWGH
AGANDLCQECEDIVHLLTKMTKEDAFQDTIRKFLEQECDILPLKLLVPRCRQVLDVYLPL
VIDYFQGQIKPKAICSHVGLCPLGQTKPEQKPEMLDAIPNPLLNKLVLPALPGAFLARPG
PHTQDLSEQQLPIPLPFCWLCRTLIKRVQAVIPKGVLAVAVSQVCHVVPLVVGGICQCLA
ERYTVLLLDALLGRVVPQLVCGLVLRCSTADAIGPALPALEPLIEKWPLQDTECHFCKSV
INQAWNTSEQAMPQAMHQACLRFWLDRQKCEQFVEQHMPQLLALVPRSQDAHTSCQALGV
CEAPASPLQCFQTPHL
>sp|P17219|PTTH_BOMMO Prothoracicotropic hormone precursor (PTTH). 
MITRPIILVILCYAILMIVQSFVPKAVALKRKPDVGGFMVEDQRTHKSHNYMMKRARNDV
LGDKENVRPNPYYTEPFDPDTSPEELSALIVDYANMIRNDVILLDNSVETRTRKRGNIQV
ENQAIPDPPCTCKYKKEIEDLGENSVPRFIETRNCNKTQQPTCRPPYICKESLYSITILK
RRETKSQESLEIPNELKYRWVAESHPVSVACLCTRDYQLRYNNN
>sp|P11953|RELX_SQUAC Relaxin. 
QSFKNAEPGIKLCGREFIRAVIYTCGGSRWEGSPGMSSKCCTYGCTRKDISILC
>sp|Q03464|RIPA_PHYAM Antiviral protein alpha precursor (PAP-alpha) (Ribosome-inactivating 
MKMMVVVVVMMLSWLILKPPSTWAINTITFDVGNATINKYATFMKSIHNQAKDPTLKCYG
IPMLPNTNLTPKYLLVTLQDSSLKTITLMLKRNNLYVMGYADTYNGKCRYHIFKDISNTT
ERNDVMTTLCPNPSSRVGKNINYDSSYPALEKKVGRPRSQVQLGIQILNSGIGKIYGVDS
FTEKTEAEFLLVAIQMVSEAARFKYIENQVKTNFNRAFYPNAKVLNLEESWGKISTAIHN
AKNGALTSPLELKNANGSKWIVLRVDDIEPDVGLLKYVNGTCQATYQSAMFPHL
>sp|P39084|RLXN_RANCA Ranalexin precursor. 
MFTLKKSLLLLFFLGTINLSLCEEERNAEEERRDNPDERDVEVEKRFLGGLIKIVPAMIC
AVTKKC
>sp|P15468|RNL4_PIG Ribonuclease PL3 precursor (EC 3.1.27.-) (Ribonuclease 4) (RNase 4). 
MALQRTHVLLLLLLLTLLGLGLVQPSYGQDRMYQRFLRQHVDPDATGGNDAYCNLMMQRR
KMTSHYCKRFNTFIHEDIWNIRSICSTSNIQCKNGQMNCHEGVVKVTDCRETGSSRAPNC
RYRAMASTRRVVIACEGNPEVPVHFDK
>sp|P80022|RNLE_LYCES Extracellular ribonuclease LE precursor (EC 3.1.27.1) (RNase LE). 
MASNSAFSLFLILLIITQCLSVLNAAKDFDFFYFVQQWPGSYCDTKQSCCYPTTGKPAAD
FGIHGLWPNNNDGTYPSNCDPNSPYDQSQISDLISSMQQNWPTLACPSGSGSTFWSHEWE
KHGTCAESVLTNQHAYFKKALDLKNQIDLLSILQGADIHPDGESYDLVNIRNAIKSAIGY
TPWIQCNVDQSGNSQLYQVYICVDGSGSSLIECPIFPGGKCGTSIEFPTF
>sp|Q01796|RNS2_SOLTU Ribonuclease S-2 precursor (EC 3.1.27.1) (Stylar glycoprotein 2) 
MAKSQLVSALFVFFFSLSPIYGDFDYMQLVLTWPRSFCYPRGFCNRIPPNNFTIHGLWPD
KKPMRGQLQFCTSDDYIKFTPGSVLDALDHHWIQLKFEREIGIRDQPLWKDQYKKHGTCC
LPRYNQLQYFLLAMRLKEKFDLLTTLRTHGITPGTKHTFKKIQDAIKTVTQEVPDLKCVE
NIQGVLELYEIGICFTPEADSLFPCRQSKSCHPTENPLILFRL
>sp|P28346|RODL_EMENI Rodlet protein precursor. 
MKFSIAAAVVAFAASVAALPPAHDSQFAGNGVGNKGNSNVKFPVPENVTVKQASDKCGDQ
AQLSCCNKATYAGDTTTVDEGLLSGALSGLIGAGSGAEGLGLFDQCSKLDVAVLIGIQDL
VNQKCKQNIACCQNSPSSADGNLIGVGLPCVALGSIL
>sp|P80097|SAKA_LACSK Bacteriocin sakacin A precursor (Curvacin A). 
MNNVKELSMTELQTITGGARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM
>sp|P35618|SAKP_LACSK Bacteriocin sakacin P precursor (Sakacin 674). 
MEKFIELSLKEVTAITGGKYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWN
K
>sp|P31226|SAX_RANCA Saxiphilin precursor (SAX). 
MAPTFQTALFFTIISLSFAAPNAKQVRWCAISDLEQKKCNDLVGSCNVPDITLVCVLRSS
TEDCMTAIKDGQADAMFLDSGEVYEASKDPYNLKPIIAEPYSSNRDLQKCLKERQQALAK
KMIGHYIPQCDEKGNYQPQQCHGSTGHCWCVNAMGEKISGTNTPPGQTRATCERHELPKC
LKERQVALGGDEKVLGRFVPQCDEKGNYEPQQFHGSTGYSWCVNAIGEEIAGTKTPPGKI
PATCQKHDLVTTCHYAVAMVKKSSAFQFNQLKGKRSCHSGVSKTDGWKALVTVLVEKKLL
SWDGPAKESIQRAMSKFFSVSCIPGATQTNLCKQCKGEEGKNCKNSHDEPYYGNYGAFRC
LKEDMGDVAFLRSTALSDEHSEVYELLCPDNTRKPLNKYKECNLGTVPAGTVVTRKISDK
TEDINNFLMEAQKRQCKLFSSAHGKDLMFDDSTLQLALLSSEVDAFLYLGVKLFHAMKAL
TGDAHLPSKNKVRWCTINKLEKMKCDDWSAVSGGAIACTEASCPKGCVKQILKGEADAVK
LEVQYMYEALMCGLLPAVEEYHNKDDFGPCKTPGSPYTDFGTLRAVALVKKSNKDINWNN
IKGKKSCHTGVGDIAGWVIPVSLIRRQNDNSDIDSFFGESCAPGSDTKSNLCKLCIGDPK
NSAANTKCSLSDKEAYYGNQGAFRCLVEKGDVAFVPHTVVFENTDGKNPAVWAKNLKSED
FELLCLDGSRAPVSNYKSCKLSGIPPPAIVTREESISDVVRIVANQQSLYGRKGFEKDMF
QLFSSNKGNNLLFNDNTQCLITFDRQPKDIMEDYFGKPYYTTVYGASRSAMSSELISACT
IKHC
>sp|P14754|SERA_MANSE Alaserpin precursor (Serpin 1). 
MKIIMCIFGLAALAMAGETDLQKILRESNDQFTAQMFSEVVKANPGQNVVLSAFSVLPPL
GQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVRAVKGVDLKMASKIYVAKGLEL
NDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVL
VNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSY
EGDQASMIIILPNQVDGITALEQKLKDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKE
VLSNMNIKKLFTPGAARLENLLKTKESLYVDAAIQKAFIEVNEEGAEAAAANAFGIVPAS
LILYPEVHIDRPFYFELKIDGIPMFNGKVIEP
>sp|Q05044|SLAP_LACBR S-layer protein precursor (Surface layer protein). 
MQSSLKKSLYLGLAALSFAGVAAVSTTASAKSYATAGAYSTLKTDAATRNVEATGTNALY
TKPGTVKGAKVVASKATMAKLASSKKSADYFRAYGVKTTNRGSVYYRVVTMDGKYRGYVY
GGKSDTAFAGGIKSAETTTKADMPARTTGFYLTDTSKNTLWTAPKYTQYKASKVSLYGVA
KDTKFTVDQAATKTREGSLYYHVTATNGSGISGWIYAGKGFSTTATGTQVLGGLSTDKSV
TATNDNSVKIVYRTTDGTQVGSNTWVTSTDGTKAGSKVSDKAADQTALEAYINANKPSGY
TVTNPNAADATYGNTVYATVSQAATSKVALKVSGTPVTTALTTADANDKVAANDTTANGS
SVAGSTVYAAGTKLAQLTTDLTGEKGQVVTLTAIDTDLEDATFTGTTTYYSDLGKAYHYT
YTYNKDSAASSNASTQFGSNVTGTLTATLVMGKSTATANGTTWFN
>sp|P06546|SLPM_BACBR Middle cell wall protein precursor (MWP). 
MKKVVNSVLASALALTVAPMAFAAEEAATTTAPKMDADMEKTVKRLEALGLVAGYGNGEY
GVDKTITRAEFATLVVRARGLEQGAKLAQFSNTYTDVKSTDWFAGFVNVASGEEIVKGFP
DKSFKPQNQVTYAEAVTMIVRALGYEPSVKGVWPNSMISKASELNIARSITTPNNAATRG
DIFKMLDNALRVDLMEQVEFGTDIRHEITKETLLTKYLKVTVRDMEWAQEAGNDSEDLPL
VTNVPAIGLGKIKANEVTLNGKDAGIGNTTYKVADGINANDFDGQHVQVWIKDDKEDVIV
WMEGSTDQEVIMDRVGEFTLKGKTFEDPKDLSNSDLADLKLELDASEKSYRFNKNTKVTY
NFTRFNDPVDGLKEIIKDNADGGFTFGAKVVLDNNNEIAYIHVIDDQSMNKEDEGVKYGS
EVISKIDTDKKKITNRDNDKFNDLDGKEEGKDFLVFLNGKPAKFSDLKEGMVYSVYYADG
DEDKLLVFATDTVVEGKVDKVVSRNNNDYRLTIGDKTYRVYEGATFSDDGNKDVQDIDKD
HWDLVDSLDDETVKLYLDASGRVRHIETKDAIDDRKQKAIVTRSATFNTSKDTWDFRVLT
QKGKEITVSLEAKNIYDFDGKNFSRDNKNQDDLEDILVPSKDKDTLLLEVTLDADGKPGK
VEFLKPVKVEQESGKAWDDLADEDDDMVGDYEVTDKTAVFNMTGKLEESSKRKELKNAKT
AKFKDVADENDLSVIYTVNDKDEVEAIFVVEGDGLTGDAHYGQVIDFGRKGGKDTIRVWE
KDGDKVVEKEYKLDGDQDDLKDEDIRRNDFIAFTVDSNDEVVVDDVVEVVNKNAKGMLAE
VTDEKGMKDANIDKMVVGLVSDVRKDTITYKDADDNKKKASIKSATVYFDLYDDFGEADG
VNEGDYVVMIDSGDISGTKYDYVLIVSDAKTVRKDKLEDDAEAFLKQEPSEKPDPDTKWD
ALPSKVEGKFTSAGPVKLYRATVELNSKVKAEDVDAIEFYFNGKKVEPSLLNFKDGVITI
GYNTEDKVTSSKIKVTNKNGKDSDEATVTFVEA
>sp|Q07449|SODE_ONCVO Extracellular superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1) 
MINSFIVIFLSFLIFINYANLVCVEATHVYGRRSHSNGMHGNGARRAVAVLRGDAGVSGI
IYFQQGSGGSITTISGSVSGLTPGLHGFHVHQYGDQTNGCTSAGDHYNPFGKTHGGPNDR
IKHIGDLGNIVAGANGVAEVYINSYDIKLRGPLSVIGHSLVVHANTDDLGQGTGNMREES
LKTGNAGSRLACGVIGIAAVS
>sp|P26774|SOM2_ACIGU Somatotropin II (Growth hormone II). 
YPMIPLSSLFTNAVLRAQYLHQLAADIYKDFERTYMPNEQRHSSKNSPSAFCYSETIPAP
TGKDEAQQRSDVELLQFSLALIQSWISPLQSLSRVFTNSLVFLTSDRVFEKLKDLEEGIV
ALMRDLGEGGFGSSTLLKLTYDMFDVNLRNNDVLFKNYGLLSCFKKDMHKVETYLKVMKC
RRFVESNCTL
>sp|Q05308|SP1_RARFA Serine protease I precursor (EC 3.4.21.-) (RPI). 
MKCKKPSALFSALALVGALGAASVLGAASANSASPVAAATVQASSGSAKTSVAATSKSQD
GDVLAAIVRDLKITKTQAKKRIKLEEKARQLEPRLQKKLGKKFAGLWISKNGKKIVVGVT
TKKAAKVVKKAGATPKIVKSNLTTLKKRATKISKNAPSDIKNVNSWWVDPATNKVVIEAR
SKKAAKAAATAAGLTAGTYEITVSDDVIVPVRDYWGGDALSGCTLAFPVYGGFLTAGHCA
VEGKGHILKTEMTGGQIGTVEASQFGDGIDAAWAKNYGDWNGRGRVTHWNGGGGVDIKGS
NEAAVGAHMCKSGRTTKWTCGYLLRKDVSVNYGNGHIVTLNETSACALGGDSGGAYVWND
QAQGITSGSNMDTNNCRSFYQPVNTVLNKWKLSLVTSTDVTTSYVQGYQNNCIDVPNSDF
TDGKQLQVWNCNGTNAQKVSFHPDGTLRINGKCLDARWAWTHNGTEVQLMNCNGHIAQKF
TLNGAGDLVNVHANKCVDVKDWGGQGGKLQLWECSGGANQKWWRR
>sp|P28592|SSI_STRGI Alkaline protease inhibitor 2C' (API-2C'). 
YAPSALVLTVGKGVSAATVTPERAVTLTCAPGPSGTHPAADSACADLAAVGGDLDALTRS
EGVMCPMIYDPVLLTVDGVWQGERVSYERVFSNECEMNAHGSSVLAF
>sp|P29608|SSI3_STRCO Subtilisin inhibitor-like protein-3 (SIL-3) (SIL3). 
YAPSALVLTVGHGESAATAAPLRAVTLTCAPTASGTHPAADAACAELRAAHGDPSALAAD
DAVMCTREYAPVVVTVDGVWQGRRLSYERTFANECVKNAGSASVFTF
>sp|P14709|STAT_MACAR Statherin. 
DSSEEKFLRRLRRFDEGRYGPYQPFVPPPLYPQPYQPYQPQY
>sp|P00735|THRB_BOVIN Prothrombin precursor (EC 3.4.21.5). 
MARVRGPRLPGCLALAALFSLVHSQHVFLAHQQASSLLQRARRANKGFLEEVRKGNLERE
CLEEPCSREEAFEALESLSATDAFWAKYTACESARNPREKLNECLEGNCAEGVGMNYRGN
VSVTRSGIECQLWRSRYPHKPEINSTTHPGADLRENFCRNPDGSITGPWCYTTSPTLRRE
ECSVPVCGQDRVTVEVIPRSGGSTTSQSPLLETCVPDRGREYRGRLAVTTSGSRCLAWSS
EQAKALSKDQDFNPAVPLAENFCRNPDGDEEGAWCYVADQPGDFEYCDLNYCEEPVDGDL
GDRLGEDPDPDAAIEGRTSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFE
SYIEGRIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNF
TVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDY
IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK
ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRD
GKYGFYTHVFRLKKWIQKVIDRLGS
>sp|P29786|TRY3_AEDAE Trypsin 3A1 precursor (EC 3.4.21.4). 
MNQFLFVSFCALLDSAKVSAATLSSGRIVGGFQIDIAEVPHQVSLQRSGRHFCGGSIISP
RWVLTRAHCTTNTDPAAYTIRAGSTDRTNGGIIVKVKSVIPHPQYNGDTYNYDFSLLELD
ESIGFSRSIEAIALPDASETVADGAMCTVSGWGDTKNVFEMNTLLRAVNVPSYNQAECAA
ALVNVVPVTEQMICAGYAAGGKDSCQGDSGGPLVSGDKLVGVVSWGKGCALPNLPGVYAR
VSTVRQWIREVSEV
>sp|P35045|TRYA_MANSE Trypsin, alkaline A precursor (EC 3.4.21.4). 
MRLFLALLALGFAAVAAVPAYPQRIVGGSTTTIQQYPTIVALLFSRNGNTFFQACGGIIL
NNRNVLTAAHCPHGDAVNRWRVRSGSTYANSGGAVHNLNRVRIHPNFNRRTLDNDIAIMR
TTSNIAFNNAAQPARIAGANYNLGDNQVVWAAGWGAIRSGGPSSEQLRHVQVWTVNQATC
RSRYASIGRSVTDNMLCSGWLDVGGRDQCQGDSGGPLYHNGVVVGVCSWGEECALARFPG
VNARVSRFANWIRNNS
>sp|Q05588|UPAR_BOVIN Urokinase plasminogen activator surface receptor precursor (U-PAR) 
MGQPLLLLLLVYTYIPGSWGLRCLQCENTTSCSVEECTPGQDLCRTTVLSVWEGGNEMNV
VRKGCTHPDKTNRSMSYRAADQIITLSETVCRSDLCNKPNPGRDATVSRNRYLECASCSS
TDLSCERGWDQTMQCLKSRDQCVDVITHRSLKENPGDERHIRGCGILPGCPGPTGFHNNH
TFHFLRCCNTTKCNAGSVLELQNLPPNGLQCYSCEGNGAHRCSSEETFLIDCRGPMNQCL
EATGTKGLRNPSYTIRGCAAPSWCQSLHVAEAFDLTHVNVSCCTGSGCNHPARDDQPGKG
GAPKTSPAHLSFFVSLLLTARLWGATLLCT
>sp|P27590|UROM_RAT Uromodulin precursor (Tamm-Horsfall urinary glycoprotein) (THP). 
MGQLLSLTWLLLVMVVTPWFTVAGANDSPEARRCSECHDNATCVLDGVVTTCSCQAGFTG
DGLVCEDIDECATPWTHNCSNSICMNTLGSYECSCQDGFRLTPGLGCIDVNECTEQGLSN
CHSLATCVNTEGSYSCVCPKGYRGDGWYCECSPGFCEPGLDCLPQGPSGKLVCQDPCNVY
ETLTEYWRSTDYGAGYSCDSDMHGWYRFTGQGGVRMAETCVPVLRCNTAAPMWLNGSHPS
SREGIVSRTACAHWSDHCCLWSTEIQVKACPGGFYVYNLTEPPECNLAYCTDPSSVEGTC
EECGVDEDCVSDNGRWRCQCKQDFNVTDVSLLEHRLECEANEIKISLSKCQLQSLGFMKV
FMYLNDRQCSGFSERGERDWMSIVTPARDGPCGTVLRRNETHATYSNTLYLASEIIIRDI
NIRINFECSYPLDMKVSLKTSLQPMVSALNISLGGTGKFTVQMALFQNPTYTQPYQGPSV
MLSTEAFLYVGTMLDGGDLSRFVLLMTNCYATPSSNSTDPVKYFIIQDRCPHTEDTTIQV
TENGESSQARFSIQMFRFAGNSDLVYLHCEVYLCDTMSEQCKPTCSGTRYRSGNFIDQTR
VLNLGPITRQGVQASVSKAASSNLGFLSIWLLLFLSATLTLMVH
>sp|P32778|VM24_BORHE Variable major outer membrane lipoprotein 24 precursor. 
MRKRISAIIMTLFMVFMSCNNGGPELKSDEVAKSDGTVLDLAKVSKKIKEASAFAASVKE
VETLVKSVDELAKAIGKKIKNDGGLDTEAGQNGSLIAGVHSVVSAVKIKVGALETTSGIS
NELKTKITEVKSKAEAFLNKLKDGHTELGKKDASDDDTKKAIKKDNSDKTKGASELEALN
TAVDALLKAAEGEVEAAIKELTAPVKAEKPSQNN
>sp|P32779|VM25_BORHE Variable major outer membrane lipoprotein 25 precursor. 
MRKRISAIINKLNISIMMMIVVLMIGCGQQAVEAGKDGAAAATGGRSLSEVLMEVGKSAE
NAFYSFMALVPDTLGLRVTKDTKKNEVGGYFNSLGGKLGKASDELEEVAKKSEVEGAKDG
PIAVAIRAAVDTAKTTLSTLKEHLESLKGIGDDDKVGEATSNQNGVAASTDELKGAFKAL
KGIVDTAGKEGVAKPKAGDTAVKIGNADNKDGAKVLAAAANAGRAVGDKAAAIVSAVSGE
EMLASIVASQEGDADAALAADATAQTSALKFARGGGNAGQLAKEAAKAAAVAGGIALRSL
VKGGKLAANNNDDDKVVQSAGVTAVNKLLVAVEGIIKKTVKNVLEKAKGEIDKARAPKAT
GQ
>sp|P23169|VP22_ASFB7 Protein P22 precursor (Protein K'177). 
MFNIKMTISTLLIALIILVIIILVVFLYYKKQQPPKKVCKVDKDCGSGEHCVRGTCSTLS
CLDAVKMDKRNIKIDSKISSCEFTPNFYRFTDTAADEQQEFGKTRHPIKITPSPSESHSP
QEVCEKYCSWGTDDCTGWEYVGDEKEGTCYVYNNPHHPVLKYGKDHIIALPRNHKHA
>sp|P06015|VSA1_TRYBB Variant surface glycoprotein AnTaT 1.1 precursor (VSG) (Expression- 
MVTKERNAALKIVMLVASALTLHPQQALAQTAGRPLADVVGKTLCTYSKTAKRQAANLAQ
TLQRASSAAKQSRQAQQLAALALAKLPDYKEAAATLLIYATHKIQDAQASIENWTGENTK
LVGQAMYSSGRIDELMLLLEGHREDGANGQDKTCLGAAAGGNTVNEFVKTECDTESGHNI
EADNSNIGQAATTLSQESTDPEASGGASCKITANLATDYDSHANELPLLGGLLTIHNAGG
FKTGQSLQTAAPTNKLISALKNKGAGVAAKLATVTSAAPTSKQELKTLLASKGERAKLQA
ANDEYNNWKPGAKPEDFDAHIKKVFGAEDGKDSAYAIALEGISIEAPLGGGQTQNKQLYS
MQPKDLMAALIGTIAELQTAAATKPACPGHKQTTTESDALCSKIKDANECNSKHFCSYNG
TETDSAKKCKYNATKASASDAPVTQAQTTSRSETPAEKCTGKKKDDCKDGCKWEAETCKD
SSILLTKNFALSVVSAALVALLF
>sp|P20950|VSG2_TRYEQ Variant surface glycoprotein 20 precursor (VSG-20). 
MFTQAVIALIGLVSIRTGKTEDVTPCTTNCGCWARLEKQITVYRGDYSAAEENLKENKKN
FGKIIAATVLGSEKLKATVAPVLLSAAQIIHECEEALTTARPAILDAEKKVAELRALYDV
QQKLKEGNGELQLHIQDDTNINTAKEVPKANLGNINKKGCADDLNTPDAATIDKTNIETE
GPTPKVITHVHVEARCQRDGTPTNGCHDGQLGQNGKLEFSLTYDSKDTNDLATWLADTAT
KKQISATEVDFIGNLNTEANTAIKGLKSSNPAPACSKKIRDYKTIADNSKFNLMVTKALI
GKTDAEAGQESKEPELAAAITKYYGTEGTKFEDQLWKAIERTPAYLGDQKKEQTTKIEKL
ETLTEVGEATARGLVKQLAAGAQARQTASGDDQSAENQCGGKKEDECKDGCELVEGVCKP
VKQGEGENKEKTGTTNTTGSNSFVIKKAPLWLAFLLF
>sp|P26326|VSI1_TRYBB Variant surface glycoprotein ILTAT 1.21 precursor (VSG). 
MLRALLPSTTLALILAGGGHAAVGDAFPAFAVLCAAWDAATNKQIKPWSEDRELPELNDI
YNMNMSIASEEWQTIFDGQAEQQTWSQFAQANAGKYKGIDWKQNWDRWRKQRQQTKDAGG
AWQTKNHRPEWAATPRDVRPVILAIAEEATELSRKLEPPRTADGKDLIAEINSKLASARC
SGELKAAAGNIGCTGPEGTPDKTTTCTTAKAGGSIGHDMLCLCSVAEATDKCSSTGVGDA
VPNSGEKLRSNGFQHIVARCPKGPESGTLPQAIDLALAMLATALGTQQPGSNNMILGKSG
GGTCTATNSACVDYHEKFSKQQAGITGIPWVALLQQARALYGTYVDAKLAAQTARQQIVM
LAGQAKREYRRPAGSLKDPAGVIQEQATNRRRHGADDTNQCTSNNATADECPETRCEYDS
EKNECRPKKGTETTATGPGERTTPADGKANNTVSDSLLIKTSPLWLAFLLF
>sp|P07208|VSIB_TRYBB Variant surface glycoprotein ILTAT 1.1BC precursor (VSG). 
MVKAIASLMLLHIWAIEEIKAERQAPSVSRTECTTPCRCAQRLEKLKKHCQMRVQTAVRK
QKENGKLAQKLLIGTITSTAGGGEQTSTTSFLLSNSSPTRRETLETNQAEIMSQLEHIIA
MEAQYYAILNVSATSTDTTLDGDGTQYNTGSITSGGFTVSKTTECNTESPEDTKEPDQTT
LSKKQGLKDLKLALRVKVACKNGGGACSAASSSDKIHITNETDSKNKGTTASTMNSQNTA
VAFATDLQIVNWKSDHIDSNITALANALTALDSIPDLTDPAAYTADAAFKQLVATVTLNK
PPTTELTGEVLDAVNRACADNYGTSASELTTKIWDPLNEQAASYYSDKTIKTDQLKLLTS
NQQLTTALGVALAKAINVKEASKKECNLHGHETDATCEAKGVGDNCKPPCKEVEEGGKKK
CKLDKEEAKRVAEQAATNQETEGKDGKTTNTTGSNSFLINKAPVLLAFLLL
>sp|P02896|VSM4_TRYBB Variant surface glycoprotein MITAT 1.4A precursor (VSG 117). 
MDCHTKETLGVTQWRRSTMLTLSLLYAITPADGAKEALEYKTWTNHCGLAATLRKVAGGV
LTKLKSHISYRKKLEEMETKLRIYALKGDGVGEQKSAEILATTAALMRQKALTPEEANLK
TALKAAGFAGEGAAAVSSYLMTLGTLTTSGSAHCLSNEGGDGDGKDQLAPKGCRHGTEAD
FDAGAGPAESEVADSGFAQVPGKQDGANAGQANMCALFTHQATPHSSQGIYITGAQTKPS
FGYGMLTIGTTDQTIGLKLSDIKGKQADSAQKFWSSCHAAVKAAQDMKADPALKVDQTLL
AVLVASPEMAEILKLEAAASQQKGPEEVTIDLATEKNNYFGTNNNKLEPLWTKIKGQNIV
DLAATKGSTKELGTVTDTAELQKLLSYYYTVNKEEQKKTAEKITKLETELADQKGKSPES
ECNKISEEPKCNEDKICSWHKEVKAGEKHCKFNSTKAKEKGVSVTQTQTAGGTEATTDKC
KGKLEDTCKKESNCKWENNACKDSSILVTKKFALTVVSAAFVALLF
>sp|P20947|VSWB_TRYBR Variant surface glycoprotein WRATAT B precursor (VSG). 
MWIILALLTLAGSRVAHGAGKNVNGVEFNLFCHIANMLNAEKIEDDKTDGLDRQAAEAWT
AIDSIFTVTANESYYSEGPASAANTTDENQDAKPERVAKWVQKRNQIDKIAAPGNEKNGK
YARRPRDRMSAATGAKLDTVFTLASEARVRLMQIDTEIATNKQEIRQQLGLHCSEGQGKG
QSRNQHPDNAAFASDYSTACKGSTGPGKSLANDLVCICSTDTSQAQSTLQMCTSIDDANS
LFSTLHKRSQCQGDFPCPHRVCAKTAETSELTETNINNCVTAFTATLGRHTKSSATNEGA
YVFGSGQNSGDECNGGAATGQSCVSYHDLITAKSGTTLSGAITRLKQLQIAKAKLKARRL
LLQNRERQQTRLMALADKMQELYQEALHDEVQLRKEAQNKPQETPDSDKQKACEKYHNKS
KECKENGCQWSGTEETIGKCEAKPKAGTEAATTGPGERDAGATANTTGSSNSFVIKTSPL
LFAFLLF
>sp|P20948|VSY1_TRYCO Variant surface glycoprotein YNAT 1.1 precursor (VSG). 
MKRVLSNVLKAWIFTIVAFHNFSTSVTADAPVNAAEYNALCRLYNIARAGEGLKEEDWLP
CAGKAACEKTAASIEDVFMKLNFSEPSAVVTTLDGTRVELQNSASTRIKRAKLAKVLAAA
ETIKAQQLKYHESSKSLLESAKANFTKAIVGGWGNPTTPDESGLPTTFKTNRADDCKLAG
GNGGKSLVFDIACLCTTSDSASGSKYTCGPKSGDNGSGWLDNNGDNQGKPAAKEAWKNLR
ADCRRQSAGVRVTPELISQSLVIFEGLIGTRAASGHDNARYIFGTVATAQSCGHSTATNK
GSIDYKASNAQQRGDIEWEKNLRMAEGDLRGLLTAKQLVAALQARAEHLEDAAFTIFNES
VLETQIAWESSRPPSTDANTSQKGPLQRPEKSGESSHLPSGSSHGTKAIRSILHVALLM
>sp|P27467|WN3A_MOUSE WNT-3A protein precursor. 
MAPLGYLLVLCSLKQALGSYPIWWSLAVGPQYSSLSTQPILCASIPGLVPKQLRFCRNYV
EIMPSVAEGVKAGIQECQHQFRGRRWNCTTVSNSLAIFGPVLDKATRESAFVHAIASAGV
AFAVTRSCAEGSAAICGCSSRLQGSPGEGWKWGGCSEDIEFGGMVSREFADARENRPDAR
SAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRTIGDFLKDKYDSASE
MVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVS
SHGIDGCDLLCCGRGHNARTERRREKCHCVFHWCCYVSCQECTRVYDVHTCK
>sp|P41221|WN5A_HUMAN WNT-5A protein precursor. 
MAGSAMSSKFFLVALAIFFSFAQVVIEANSWWSLGMNNPVQMSEVYIIGAQPLCSQLAGL
SQGQKKLCHLYQDHMQYIGEGAKTGIKECQYQFRHRRWNCSTVDNTSVFGRVMQIGSRET
AFTYAVSAAGVVNAMSRACREGELSTCGCSRAARPKDLPRDWLWGGCGDNIDYGYRFAKE
FVDARERERIHAKGSYESARILMNLHNNEAGRRTVYNLADVACKCHGVSGSCSLKTCWLQ
LADFRKVGDALKEKYDSAAAMRLNSRGKLVQVNSRFNSPTTQDLVYIDPSPDYCVRNEST
GSLGTQGRLCNKTSEGMDGCELMCCGRGYDQFKTVQTERCHCKFHWCCYVKCKKCTEIVD
QFVCK
>sp|P09544|WNT2_HUMAN WNT-2 protein precursor (IRP protein) (Int-1 related protein). 
MNAPLGGIWLWLPLLLTWLTPEVNSSWWYMRATGGSSRVMCDNVPGLVSSQRQLCHRHPD
VMRAISQGVAEWTAECQHQFRQHRWNCNTLDRDHSLFGRVLLRSSRESAFVYAISSAGVV
FAITRACSQGEVKSCSCDPKKMGSAKDSKGIFDWGGCSDNIDYGIKFARAFVDAKERKGK
DARALMNLHNNRAGRKAVKRFLKQECKCHGVSGSCTLRTCWLAMADFRKTGDYLWRKYNG
AIQVVMNQDGTGFTVANERFKKPTKNDLVYFENSPDYCIRDREAGSLGTAGRVCNLTSRG
MDSCEVMCCGRGYDTSHVTRMTKCGCKFHWCCAVRCQDCLEALDVHTCKAPKNADWTTAT
>sp|Q00223|XP4_XENLA Putative gastrointestinal growth factor XP4 precursor. 
MANSVFWAIAVALVLGAEAYMPLDYRCGVKPKSRDNCGPPGISPDECVKKGCCFDDSDPD
SIWCYTPWKFEDTICNPAEPKARVNCGYPGITSQDCDKKGCCFNDTIPNVVWCYQPIIEA
VERDCSAVEPKKRVNCGPPGVSPDECIKNGCCFNSDVGGVPWCFKPEIKKELLQCAVLPK
ARINCGYPDITMDQCYKKGCCYDSSESDSIWCFYPDIEDVTIIE
>sp|Q06562|XYN1_COCCA Endo-1,4-beta-xylanase I precursor (EC 3.2.1.8) (Xylanase I) 
MVSFTSIITAAVAATGALAAPATDVSLVARQNTPNGEGTHNGCFWSWWSDGGARATYTNG
AGGSYSVSWGSGGNLVGGKGWNPGTARTITYSGTYNYNGNSYLAVYGWTRNPLVEYYVVE
NFGTYDPSSQSQNKGTVTSDGSSYKIAQSTRTNQPSIDGTRTFQQYWSVRQNKRSSGSVN
MKTHFDAWASKGMNLGQHYYQIVATEGYFSTGNAQITVNCP
>sp|Q00926|YSCJ_YERPE Yop proteins translocation lipoprotein J precursor (YlpB lipoprotein) 
MKVKTSLSTLILILFLTGCKVDLYTGISQKEGNEMLALLRQEGLSADKEPDKDGKIKLLV
EESDVAQAIDILKRKGYPHESFSTLQDVFPKDGLISSPIEELARLNYAKAQEISRTLSEI
DGVLVARVHVVLPEEQNNKGKKGVAASASVFIKHAADIQFDTYIPQIKQLVNNSIEGLAY
DRISVILVPSVDVRQSSHLPRNTSILSIQVSEESKGHLIGLLSLLILLLPVTNLAQYFWL
QRKK
>sp|P25311|ZA2G_HUMAN Zinc-alpha-2-glycoprotein precursor (Zn-alpha-2-glycoprotein) 
MVPVLLSLLLLLGPAVPQENQDGRYSLTYIYTGLSKHVEDVPAFQALGSLNDLQFFRYNS
KDRKSQPMGLWRQVEGMEDWKQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGC
EIENNRSSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLE
EECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEKKKLKCLAYDFYPGKIDVHWTRAG
EVQEPELRGDVLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEAS
>sp|Q06633|ZP3B_HUMAN Zona pellucida sperm-binding protein 3B precursor (Zona pellucida 
MELSYRLFICLLLWGSTELCYPQPLWLLQGGASHPETSVQPVLVECQEATLMVMVSKDLF
GTGKLIRAADLTLGPEACEPLVSMDTEDVVRFEVGLHECGNSMQVTDDALVYSTFLLHDP
RPVGNLSIVRTNRAEIPIECRYPRQGNVSSQAILPTWLPFRTTVFSEEKLTFSLRLMEEN
WNAEKRSPTFHLGDAAHLQAEIHTGSHVPLRLFVDHCVATPTPDQNASPYHTIVDFHGCL
VDGLTDASSAFKVPRPGPDTLQFTVDVFHFANDSRNMIYITCHLKVTLAEQDPDELNKAC
SFSKPSNSWFPVEGPADICQCCNKGDCGTPSHSRRQPHVMSQWSTSASRNRRHVTEEADV
TVGATDLPGQEW
